Inventergy Global 10-Q 7 Aug 15 2015 Q2 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	6 Months Ended
	Jun. 30, 2015	Aug. 06, 2015
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2015
Document Fiscal Year Focus	2,015
Document Fiscal Period Focus	Q2
Entity Registrant Name	Inventergy Global, Inc.
Entity Central Index Key	1,084,752
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Trading Symbol	INVT
Entity Common Stock, Shares Outstanding		36,518,792

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Jun. 30, 2015	Dec. 31, 2014
Current assets
Cash and cash equivalents	$ 5,449,313	$ 1,443,349
Accounts receivable	53,525	259,049
Inventories	172,584	302,739
Prepaid expenses and other current assets	331,288	212,280
Deferred expenses, current	2,684,942	3,000,000
Total current assets	8,691,652	5,217,417
Property and equipment, net	33,765	42,267
Deferred expenses, patents	12,880,031	12,094,420
Patents, net	9,425,409	10,415,404
Intangible assets, net	442,583	499,083
Goodwill	8,858,504	8,858,504
Debt issuance costs	664,414	729,498
Deposits and other assets	28,993	18,993
Total assets	41,025,351	37,875,586
Current liabilities
Accounts payable	1,439,133	1,501,938
Accrued expenses and other current liabilities	666,223	301,132
Short-term notes payable, related party	200,000	300,000
Guaranteed payments, current	4,914,413	3,807,084
Fortress notes payable, current	4,675,210	1,421,196
Deferred revenue	400,000	0
Total current liabilities	12,294,979	7,331,350
Deferred revenue, non-current	196,429	0
Guaranteed payments	12,880,029	13,105,857
Derivative liabilities	59,262	30,278
Fortress notes payable, net of discount	5,028,729	6,259,321
Fortress revenue share, net of discount	5,549,367	2,478,057
Total liabilities	36,008,795	29,204,863
Stockholders' equity
Common stock, $0.001 par value; 100,000,000 shares authorized, 36,518,792 and 27,997,128 shares issued and outstanding at June 30, 2015 and December 31, 2014	36,519	27,997
Additional paid-in capital	54,077,355	51,713,228
Deficit accumulated	(49,097,693)	(43,073,213)
Total stockholders' equity	5,016,556	8,670,723
Total liabilities and stockholders' equity	41,025,351	37,875,586
Series A Convertible Preferred Stock [Member]
Stockholders' equity
Preferred stock, $0.001 par value, 10,000,000 shares authorized	374	2,710
Series B Convertible Preferred Stock [Member]
Stockholders' equity
Preferred stock, $0.001 par value, 10,000,000 shares authorized	$ 1	$ 1

CONDENSED CONSOLIDATED BALANCE3

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)	Jun. 30, 2015	Dec. 31, 2014
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	10,000,000	10,000,000
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	36,518,792	27,997,128
Common stock, shares outstanding	36,518,792	27,997,128
Series A Convertible Preferred Stock [Member]
Preferred stock shares designated	6,176,748	6,176,748
Preferred stock, shares issued	373,821	2,709,690
Preferred stock, shares outstanding	373,821	2,709,690
Temporary equity, liquidation preference	$ 469,503	$ 2,915,122
Series B Convertible Preferred Stock [Member]
Preferred stock shares designated	2,750	2,750
Preferred stock, shares issued	1,102	1,102
Preferred stock, shares outstanding	1,102	1,102
Temporary equity, liquidation preference	$ 1,102,000	$ 1,102,000

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Revenues	$ 4,183,891	$ 47,044	$ 4,350,803	$ 47,044
Operating Expenses
Cost of revenues	792,483	78,205	862,150	78,205
Patent amortization expense	387,038	292,815	774,623	625,371
General and administrative	1,164,946	3,399,763	3,990,506	6,437,386
Total operating expenses	2,344,467	3,770,783	5,627,279	7,140,962
Income (loss) from operations	1,839,424	(3,723,739)	(1,276,476)	(7,093,918)
Other income (expense)
Loss on extinguishment of notes payable	0	0	(2,268,373)	(2,403,193)
Decrease (increase) in fair value of derivative liabilities	5,435	(78,682)	12,321	395,644
Other income	0	0	37	0
Interest expense, net	(1,243,506)	(129,892)	(2,491,989)	(296,160)
Total other (expense), net	(1,238,071)	(208,574)	(4,748,004)	(2,303,709)
Income (loss) before provision for income taxes	601,353	(3,932,313)	(6,024,480)	(9,397,627)
Provision for income taxes	0	0	0	0
Net income (loss)	601,353	(3,932,313)	(6,024,480)	(9,397,627)
Net income (loss) available to common shareholders	$ 601,353	$ (3,932,313)	$ (6,024,480)	$ (9,397,627)
Basic income (loss) per share	$ 0.02	$ (0.27)	$ (0.20)	$ (0.69)
Fully diluted income (loss) per share	$ 0.02	$ (0.27)	$ (0.20)	$ (0.69)
Weighted average shares outstanding:
Basic	34,301,770	14,613,039	30,611,175	13,577,273
Fully diluted	36,418,044	14,613,039	30,611,175	13,577,273

CONDENSED CONSOLIDATED STATEME5

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - Class of Stock [Domain] - USD ($)	6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
Cash flows from operating activities
Net loss	$ (6,024,480)	$ (9,397,627)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation expense	8,502	0
Loss on extinguishment of notes payable	2,268,373	2,403,193
Decrease in fair value of derivative liabilities	(12,321)	(395,644)
Amortization of discount on notes payable	1,740,150	201,574
Amortization of patents and acquired contracts	831,123	647,738
Net cost of patents sold	215,372	0
Stock-based compensation	596,901	1,861,654
Changes in operating assets and liabilities
Accounts receivable	205,524	(45,965)
Inventories	130,155	15,345
Prepaid expenses and other current assets	(119,008)	(344,953)
Deferred expenses	315,058	0
Deposits and other assets	(10,000)	(16,113)
Accounts payable	(62,805)	426,035
Accrued expenses and other current liabilities	365,091	0
Accrued interest on notes payable	0	73,065
Deferred revenue	596,429	0
Net cash provided by (used in) operating activities	1,044,064	(4,571,698)
Cash flows from investing activities
Restricted cash	0	(3,500,000)
Purchases of property and equipment	0	(45,961)
Issuance of short-term note receivable, related party	0	(3,000,000)
Cash and other assets received in acquisition	0	790,172
Net cash used in investing activities	0	(5,755,789)
Cash flows from financing activities
Proceeds from issuance of common stock, net of issuance costs	1,835,000	6,487,850
Proceeds from issuance of convertible notes payable, net of issuance costs	0	2,905,128
Proceeds from issuance of notes payable	1,126,900	0
Payments on short-term notes payable, related party	0	(100,000)
Net cash provided by financing activities	2,961,900	9,292,978
Net increase (decrease) in cash and cash equivalents	4,005,964	(1,034,509)
Cash and cash equivalents, beginning of period	1,443,349	1,518,684
Cash and cash equivalents, end of period	5,449,313	484,175
Supplemental disclosures of cash flow information
Cash paid for interest	481,838	83,777
Cash paid for income taxes	0	0
Supplemental disclosures of non-cash investing and financing activities
Accrued guaranteed payments and deferred expenses associated with purchased patent assets	881,501	1,599,977
Conversion of portion of short term note payable, related party, to purchase common stock	100,000	0
Offset of short-term related party notes payable and receivable	0	3,000,000
Transfer of Series A redeemable convertible preferred stock to preferred stock	0	3,392,950
Fair value of convertible notes payable redemption derivative liability	0	385,000
Fair value of common stock warrants	0	348,963
Acquisition of patents	$ 0	$ 2,653,533

Organization

Organization	6 Months Ended
	Jun. 30, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization	1. Organization Inventergy Global, Inc. (“we”, “us”, “our”, “Inventergy”, or the “Company”) is an intellectual property (IP) investment and licensing company that helps technology-leading corporations attain greater value from their IP assets in support of their business objectives and corporate brands. Inventergy, Inc. was initially organized as a Delaware limited liability company under the name Silicon Turbine Systems, LLC in January 2012. It subsequently changed its name to Inventergy, LLC in March 2012 and it was converted from a limited liability company into a Delaware corporation in February 2013. On June 6, 2014, a subsidiary (“Merger Sub”) of eOn Communications Corporation (“eOn”) merged with and into Inventergy, Inc. with Inventergy, Inc. surviving (the “Merger”). As a result of the Merger, eOn changed its name to “Inventergy Global, Inc.” The Company is headquartered in Campbell, California. The Company operates in a single industry segment.

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
	Jun. 30, 2015
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	2. Summary of Significant Accounting Policies The consolidated financial statements have been prepared on the accrual basis of accounting in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The consolidated financial statements include the accounts of the Company and its subsidiaries. All material intercompany accounts and transactions have been eliminated in consolidation. The accompanying interim financial statements are condensed and should be read in conjunction with the Company’s latest annual financial statements. It is management’s opinion that all adjustments necessary for a fair presentation of the results for the interim periods have been made, and all such adjustments were of a normal recurring nature. At June 30, 2015, the Company had an accumulated deficit since inception of $ 49,097,693 3,603,327 August 6, 2015 3,016,667 1,000,000 1,126,900 1,835,000 4,000,000 The business may require significant amounts of capital over the next twelve months to sustain operations and make the investments it needs to continue operations and execute its longer term business plan. We believe that cash required for operating expenses will be approximately $ 6.5 2.4 0.8 0.8 2.5 4.4 2.4 2 Based on our existing cash balances, anticipated revenues from patent monetization activities, proactive measures to reduce expenses and defer obligations where possible, management believes we have funds sufficient to meet our anticipated operating needs for approximately five months. To date, the Company has acquired an aggregate of approximately 755 currently active patents and patent applications for aggregate purchase payments of $ 12,109,118 20 18 17.8 As of June 30, 2015, the Company had cash and cash equivalents of $ 5,449,313 1,000,000 3,603,327 6,024,480 49,097,693 The Company will also require additional financing for the purchase of additional patent portfolios and to fund their monetization efforts if new attractive opportunities are found. If the Company acquires additional large patent portfolios, in addition to the cost of the upfront purchase fee (if any) it is likely that additional resources (business, technical or legal) may need to be hired to effectively monetize the portfolio. Resources to analyze new portfolios are already part of the current staffing of the Company. Litigation costs are based primarily on a contingent fee structure (expected to average less than 20% of license revenue for a portfolio) and as such do not scale significantly with the acquisition of new portfolios. The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions about the reported amounts of assets and liabilities, and disclosures of contingent assets and liabilities, at the dates of the financial statements and the reported amounts of revenues and expenses during the reported periods. Although these estimates reflect management's best estimates, it is at least reasonably possible that a material change to these estimates could occur in the near term. Revenue is recognized when (i) persuasive evidence of an arrangement exists, (ii) all obligations have been substantially performed pursuant to the terms of the arrangement, (iii) amounts are fixed or determinable, and (iv) the collectability of amounts is reasonably assured. Licensing Fees We derive revenue primarily from the monetization of acquired patents, either through licensing agreements or outright sales of patents. In general, licensing arrangements provide for the payment of contractually determined fees in consideration for the grant of certain intellectual property rights for patented technologies owned or controlled by the Company. These rights typically include some combination of the following: (i) the grant of a non-exclusive, retroactive and future license to manufacture and/or sell products covered by patented technologies, (ii) a covenant-not-to-litigate, (iii) the release of the licensee from certain claims, and (iv) the dismissal of any pending litigation. The intellectual property rights granted may be perpetual in nature, extending until the expiration of the related patents, or can be granted for a defined period of time, with the licensee possessing the right to renew the agreement at the end of each contractual term for additional payments. The Company recognizes licensing fees when there is persuasive evidence of a licensing arrangement, fees are fixed or determinable, delivery has occurred and collectability is reasonably assured. Patent Sales The Company’s patent monetization efforts also include the sale of select patent assets. As patent sales represents a component of the Company’s ongoing major or central operations and activities, the Company records the related proceeds as revenue. The Company recognizes the patent sales revenue when there is persuasive evidence of a sales arrangement, fees are fixed or determinable, delivery has occurred and collectability is reasonably assured. These requirements are generally fulfilled upon closing of the patent sale transaction. Amounts related to revenue arrangements that do not meet the revenue recognition criteria described above are deferred until the revenue recognition criteria are met. The Company assesses the collectability of fees receivable based on a number of factors, including past transaction history and credit-worthiness of licensees. If it is determined that collection is not reasonably assured, the fee is recognized when collectability becomes reasonably assured, assuming all other revenue recognition criteria have been met. Cost of revenues primarily include the costs of patents sold, and other amounts paid to third parties, including technical consultants and intellectual property counsel, under revenue sharing agreements. These costs are included under the caption “Cost of Revenues” in the accompanying Condensed Consolidated Statement of Operations. Contingent legal fees are expensed in the Condensed Consolidated Statement of Operations in the period that such fees are determined to be probable, usually when the related revenues are recognized. In instances where there are no recoveries from potential infringers, no contingent legal and consulting fees are paid; however, the Company may be liable for certain out of pocket legal and consulting costs incurred pursuant to the underlying legal and consulting services agreement. In the three months ended June 30, 2015, the Company discovered certain legal fees had been expensed in prior periods which were contingent in nature and whose probability had not yet been determined. Such fees, which were not material to the individual prior periods, were reversed in the three month period ended June 30, 2015. The Company considers all highly liquid financial instruments with original maturities of three months or less at the time of purchase to be cash equivalents. Accounts receivable are stated net of allowances for doubtful accounts. The Company typically grants standard credit terms to customers in good credit standing. The Company generally reserves for estimated uncollectible accounts on a customer-by-customer basis, which requires judgment about each individual customer’s ability and intention to fully pay account balances. The Company makes these judgments based on knowledge of and relationships with customers and current economic trends, and updates estimates on a monthly basis. Any changes in estimate, which can be significant, are included in earnings in the period in which the change in estimate occurs. As of June 30, 2015, the Company has not established any reserves for uncollectable accounts. Inventories consist of finished goods and some component and spare parts. Inventory is valued at the lower of cost or market with cost determined utilizing standard cost which approximates the first-in, first-out (FIFO) method. The Company performs an analysis of slow-moving or obsolete inventory on a regular basis and any changes in valuation reserves, which could potentially be significant, are included in earnings in the period in which the evaluations are completed. Property and equipment are recorded at cost less accumulated depreciation and amortization. Depreciation and amortization are computed using the straight-line method over the estimated useful lives of the assets (or the term of the lease, if shorter), which range from three to five years. Routine maintenance and repair costs are expensed as incurred. The costs of major additions, replacements and improvements are capitalized. Upon retirement or sale, the cost of assets disposed and the related accumulated depreciation is removed and any resulting gain or loss is credited or charged to operations. Patents Patents, including acquisition costs, are stated at cost, less accumulated amortization. Amortization is computed using the straight-line method over the estimated useful lives of the respective assets, generally 7 10 Intangible Assets Intangible assets consist of certain contract rights acquired in the Merger. Intangible assets are amortized on a straight-line basis over their estimated useful life of five years. Goodwill Goodwill represents the excess of the aggregate purchase price over the fair value of the net tangible and identifiable intangible assets acquired by the Company. The carrying amount of goodwill will be tested for impairment annually or more frequently if facts and circumstances warrant a review. The Company determined that it is a single reporting unit for the purpose of goodwill impairment tests. For purposes of assessing the impairment of goodwill, the Company estimates the value of the reporting unit using its market capitalization as the best evidence of fair value. This fair value is then compared to the carrying value of the reporting unit. Impairment of long-lived assets The Company evaluates the carrying value of long-lived assets on an annual basis, or more frequently whenever circumstances indicate a long-lived asset may be impaired. When indicators of impairment exist, the Company estimates future undiscounted cash flows attributable to such assets. In the event cash flows are not expected to be sufficient to recover the recorded value of the assets, the assets are written down to their estimated fair value. On December 31, 2014, the Company recorded an impairment charge of $ 686,350 Financial instruments that potentially subject the Company to a concentration of credit risk consist of cash and cash equivalents. Cash and cash equivalents are deposited with high quality financial institutions. Periodically, such balances are from time to time in excess of federally insured limits. The Company has a stock option plan under which incentive and non-qualified stock options and restricted stock awards (“RSAs”) are granted primarily to employees. All share-based payments to employees, including grants of employee stock options and RSAs, are recognized in the financial statements based on their respective grant date fair values. The benefits of tax deductions in excess of recognized compensation cost are reported as a financing cash flow. The Company estimates the fair value of share-based payment awards on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as expense ratably over the requisite service periods in the Company’s statements of comprehensive income or loss. The Company has estimated the fair value of each option award as of the date of grant using the Black-Scholes option pricing model. The fair value of RSAs is calculated as the fair value of the underlying stock multiplied by the number of shares awarded. The awards issued consist of fully-vested stock awards, performance-based restricted shares, and service-based restricted shares. Expenses related to stock-based awards issued to non-employees are recognized at fair value on a recurring basis in the periods those awards are expected to vest. The Company estimates the fair value of the awards using the Black-Scholes option pricing model. The Company accounts for income taxes using the asset and liability method whereby deferred tax asset and liability account balances are determined based on temporary differences between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to affect taxable income. A valuation allowance is established when it is more likely than not that deferred tax assets will not be realized. Realization of deferred tax assets is dependent upon future pretax earnings, the reversal of temporary differences between book and tax income, and the expected tax rates in future periods. The Company has a full valuation allowance on all deferred tax assets. The Company is required to evaluate the tax positions taken in the course of preparing its tax returns to determine whether tax positions are “more-likely-than-not” of being sustained by the applicable tax authority. Tax benefits of positions not deemed to meet the more-likely-than-not threshold would be recorded as a tax expense in the current year. The amount recognized is subject to estimate and management judgment with respect to the likely outcome of each uncertain tax position. The amount that is ultimately sustained for an individual uncertain tax position or for all uncertain tax positions in the aggregate could differ from the amount that is initially recognized. The Company defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs within the fair value hierarchy. Observable inputs are inputs that market participants would use in pricing the asset or liability developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company’s own assumptions about what market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. The following methods and assumptions were used to estimate the fair value of financial instruments: ⋅ Level 1 - Valuation is based upon quoted prices for identical instruments traded in active markets. ⋅ Level 2 - Valuation is based upon quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market. ⋅ Level 3 - Valuation is generated from model-based techniques that use significant assumptions not observable in the market. These unobservable assumptions reflect management’s estimates of assumptions that market participants would use in pricing the asset or liability. Valuation techniques include use of option pricing models, discounted cash flow models and similar techniques. The category within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. In May 2014, the FASB issued a new financial accounting standard which outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes current revenue recognition guidance. ASU 2014-09 Revenue from Contracts with Customers is effective for annual reporting periods (including interim reporting periods within those periods) beginning after December 15, 2017. Early adoption is not permitted. We are currently evaluating the impact of this accounting standard. In June 2014, the FASB issued Accounting Standards Update (“ASU”) ASU 2014-10 Development Stage Entities. The amendments in ASU 2014-10 remove the definition of a development stage entity from Topic 915 Development Stage Entities, thereby removing the distinction between development stage entities and other reporting entities from US GAAP. In addition, the amendments eliminate the requirements for development stage entities to (1) present inception-to-date information in the statements of operations, cash flows, and shareholder’s equity, (2) label the financial statements as those of a development stage entity, (3) disclose a description of the development stage activities in which the entity is engaged, and (4) disclose in the first year in which the entity is no longer a development stage entity that in prior years it had been in the development stage. The amendments also clarify that the guidance in Topic 275, Risks and Uncertainties, is applicable to entities that have not commenced planned principal operations. ASU 2014-10 is effective for annual reporting periods beginning after December 15, 2014, and interim periods therein. The Company could early adopt ASU 2014-10 for any annual reporting period or interim period for which the entity’s financial statements have not yet been issued. The Company elected to adopt this ASU beginning with the June 30, 2014 Quarterly Report on Form 10-Q and its adoption resulted in the removal of inception-to-date information in the Company’s statements of operations and cash flows. In August 2014, the FASB issued a new accounting standard which requires management to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern for each annual and interim reporting period and to provide related footnote disclosures in certain circumstances. ASU 2014-15 Presentation of Financial Statements - Going Concern is effective for annual reporting periods (including interim reporting periods within those periods) beginning after December 15, 2016. Early adoption is permitted. We are currently evaluating the impact of this accounting standard. In April 2015, the FASB issued a new accounting standard which changes the presentation of debt issuance costs in financial statements. Under the new standard, an entity presents such costs in the balance sheet as a direct deduction from the related debt liability rather than as an asset. Amortization of the costs is reported as interest expense. The accounting standard is effective for annual reporting periods beginning after December 15, 2015 and interim periods beginning after December 15, 2016. Early adoption is allowed for all entities for financial statements that have not been previously issued. The adoption of this standard is not expected to have a material impact on the Company’s consolidated financial statements.

Business Combination

Business Combination	6 Months Ended
	Jun. 30, 2015
Business Combinations [Abstract]
Business Combination	3. Business Combination The Merger was consummated on June 6, 2014, as a result of which Inventergy, Inc. merged with and into Merger Sub and holders of Inventergy, Inc. securities were issued securities of the Company. Upon the consummation of the Merger, the Company changed its name from “eOn Communications Corporation” to “Inventergy Global, Inc.” and effected a one-for-two reverse stock split of the Company’s common stock (the “Reverse Split”). The primary reason for the Merger was to allow the Company access to the public equity market for financing. In connection with the consummation of the Merger: (i) each share of the pre-Merger Inventergy, Inc. common stock was exchanged for 1.4139 (ii) the pre-Merger Inventergy, Inc. Series A Preferred Stock was exchanged for a like number of newly-created Company Series A Preferred Stock (as defined below); (iii) options and restricted shares of pre-Merger Inventergy, Inc. common stock awarded pursuant to the Inventergy 2014 Stock Plan (such stock plan being adopted by the stockholders of the Company in connection with the Merger) and outstanding immediately prior to the consummation of the Merger were converted into awards of options to purchase Company common stock and restricted shares of Company common stock with terms and conditions identical to the terms and conditions of the corresponding options to purchase Inventergy, Inc. common stock and awards of restricted shares of Inventergy, Inc. common stock (as adjusted for the Exchange Ratio); and (iv) outstanding warrants to purchase pre-Merger Inventergy, Inc. common stock were exchanged for warrants to acquire Company common stock with terms and conditions identical to the terms and conditions of the corresponding warrants to purchase Inventergy, Inc. common stock (as adjusted for the Exchange Ratio). Immediately following the consummation of the Merger, the Company had 20,018,028 6,176,748 2,231 700,937 238,412 The Transition Transactions In connection with the Merger, on December 17, 2013, eOn, Cortelco Systems Holding Corp., a Delaware corporation and wholly-owned subsidiary of eOn (“Cortelco Holding”), eOn Communications Systems, Inc., a Delaware corporation and wholly-owned subsidiary of eOn (“eOn Subsidiary”), and Cortelco, Inc., a Delaware corporation and wholly-owned subsidiary of Cortelco Holding (“Cortelco”) entered into a transition agreement (the “Transition Agreement”). The Transition Agreement provided for several transactions among eOn and its subsidiaries in connection with, and subject to the completion of, the Merger. Each of these transactions were consummated at the time the Merger became effective (the “Effective Time”), including the following (collectively, the “Transition Transactions”): (1) eOn and Cortelco each transferred certain contracts and other assets to eOn Subsidiary, and eOn Subsidiary assumed the liabilities associated with such contracts on and after the date of assumption; (2) eOn Subsidiary purchased from Cortelco certain inventory for a purchase price equal to Cortelco’s book value of such inventory; (3) eOn and Cortelco Holding redeemed in full those certain contingent notes in the maximum initial amount of $ 11 300,000 (4) Cortelco entered into a fulfillment services agreement with eOn Subsidiary providing for certain services to be conducted on behalf of eOn Subsidiary after the Merger; (5) the Company transferred to Cortelco Holding (i) all of its ownership in Cortelco Systems Puerto Rico, Inc., and Symbio Investment Corp., and (ii) eOn’s right to require David S. Lee, former Chairman of eOn, to purchase its investment in Symbio Investment Corp.; and (6) the Company and Cortelco Holding entered into an indemnity agreement providing that Cortelco will indemnify the Company from and against any future losses arising from the Contingent Note and certain other matters. Upon completion of the Merger and the Transition Transactions, the Company owned all of the outstanding stock of Inventergy, Inc. and eOn Subsidiary and has transferred certain assets held prior to the Merger and no longer owned an interest in Cortelco Holding, Cortelco, Cortelco Systems Puerto Rico, Inc., or Symbio Investment Corp. Fair value of assumed equity allocated to purchase consideration $ 10,985,867 Total purchase consideration $ 10,985,867 Goodwill $ 8,858,504 Intangible asset contract rights 1,342,000 Other assets acquired 816,045 Liabilities assumed (30,682) Total purchase allocation $ 10,985,867 Goodwill of $ 8,858,504 1,342,000 686,350 Acquisition-related costs directly attributable to the Merger totaling $ 1,237,641 The consideration in the Merger was based on fair value of equity retained by eOn shareholders on June 6, 2014, the date of the Merger close. The historical financial information is that of Inventergy, Inc.

Patents

Patents	6 Months Ended
	Jun. 30, 2015
Goodwill and Intangible Assets Disclosure [Abstract]
Patents	4. Patents Weighted Average Gross Carrying Accumulated Net Carrying Useful Life Amount Amortization Amount Amortizable intangible assets: Patents 8.0 $ 11,893,745 $ (2,468,336) $ 9,425,409 Total patent intangible assets $ 11,893,745 $ (2,468,336) $ 9,425,409 The Company expects amortization expense to be approximately $ 1,510,977

Fair Value Measurements

Fair Value Measurements	6 Months Ended
	Jun. 30, 2015
Fair Value Disclosures [Abstract]
Fair Value Measurements	5. Fair Value Measurements June 30, 2015 Fair Value (Level 1) (Level 2) (Level 3) Common stock warrants $ 59,262 $ - $ - $ 59,262 Total $ 59,262 $ - $ - $ 59,262 December 31, 2014 Fair Value (Level 1) (Level 2) (Level 3) Common stock warrants $ 30,278 $ - $ - $ 30,278 Total $ 30,278 $ - $ - $ 30,278 Prior to the Merger, the Company issued senior secured promissory notes (the “Senior Secured Notes”) with an aggregate principal amount of $ 5,000,000 3,000,000 In May 2013, the Company sold Series A-1 redeemable convertible preferred stock (“Series A-1 Preferred Stock”) which contained provisions for anti-dilution protection in the event the Company issues common stock at a price below a price per share formula, as defined. At June 30, 2015, the threshold price was $ 0.289 As discussed in Note 7, in January 2014, the Company issued warrants to purchase 238,412 3.04 2.27 Expected volatility 60 % Risk free rate 1.05 % Dividend yield 0 % Expected term (in years) 3.8226 The assumptions utilized were derived in a similar manner as discussed in Note 7 related to the fair value of stock options. The Company revalues the derivative liabilities at the end of each reporting period using the same models as at issuance, updated for new facts and circumstances, and recognizes the change in the fair value in the statements of operations as other income (expense). Series A-1 Convertible Preferred Common Notes Payable Stock Stock Derivative Liability Derivative Liability Warrants Balance at December 31, 2013 $ 534,975 $ 56,926 $ - Extinguishment (118,300) - - Fair value at issuance 189,300 - 466,706 Change in fair value (220,975) (56,926) (117,743) Balance at June 30, 2014 $ 385,000 $ - $ 348,963 Series A-1 Convertible Preferred Common Notes Payable Stock Stock Derivative Liability Derivative Liability Warrants Balance at December 31, 2014 $ - $ - $ 30,278 Fair value at issuance - - 41,305 Change in fair value - - (12,321) Balance at June 30, 2015 $ - $ - $ 59,262

Borrowing Arrangements

Borrowing Arrangements	6 Months Ended
	Jun. 30, 2015
Debt Disclosure [Abstract]
Borrowing Arrangements	6. Borrowing Arrangements On March 26, 2014, notes payable which have since been retired were amended and restated to allow for conversion to common stock and to amend the interest rate. In conjunction with the amendment, the Company recorded a loss on extinguishment of the notes payable of $ 2,403,193 On September 23, 2014, the Company entered into a Share Purchase Agreement with the Company’s Chief Executive Officer pursuant to which the Company agreed to issue to the Chief Executive Officer up to 233,640 2.14 500,000 300,000 6 300,000 100,000 0.46 217,392 0.46 200,000 On October 1, 2014 the Company entered into the original Fortress Agreement with Fortress, including a Note Purchaser (as defined below) who also serves as collateral agent (the “Collateral Agent”) and a Revenue Participant (as defined below). Pursuant to the original Fortress Agreement, the Company issued an aggregate of $ 11,000,000 9,964,868 450,253 500,000 The principal of the Original Notes and all unpaid interest thereon or other amounts owing hereunder shall be paid in full in cash by the Company on September 30, 2017 (the “Maturity Date”). The Company may prepay the Original Notes in whole or in part, generally without penalty or premium, except that any optional prepayments of the Original Notes prior to October 1, 2015 will be accompanied by a prepayment premium equal to 5 770,000 In addition to the Mandatory Prepayments, beginning on the last business day of October 2015, the Company shall make monthly amortization payments (the “Amortization Payments”) in an amount equal to (x) the then outstanding principal amount of the Original Notes divided by (y) the number of months left until the Maturity Date. In connection with the execution of the Fortress Agreement, on October 1, 2014, the Company paid to the Note Purchasers a structuring fee equal to $ 385,000 Pursuant to the Fortress Agreement, the Company granted to the purchasers identified in the Fortress Agreement (“Revenue Participants”) a right to receive a portion of the Company’s Monetization Revenues totaling $5,500,000 (unless the Revenue Participants have not received $5,500,000 by the Maturity Date, in which case the Revenue Participants have a right to receive a portion of Monetization Revenues totaling $8,250,000) (the “Revenue Stream”). The Revenue Participants will not receive any portion of the Revenue Stream until all obligations under the Original Notes are paid in full. Following payment in full of the Original Notes, the Company will pay to the Revenue Participants their proportionate share of the Monetization Net Revenues. The Revenue Participants’ proportionate share is equal to (a) 46% of Monetization Net Revenues until $2,750,000 has been paid to the Revenue Participants, (b) 31% of Monetization Net Revenues until the next $2,750,000 has been paid to the Revenue Participants and (c) 6% of Monetization Net Revenues until the next $2,750,000 has been paid to the Revenue Participants if (a) and (b) have not been fully paid by the Maturity Date. All Revenue Stream Payments will be payable on a monthly basis in arrears. The rights of the Revenue Participants to the Revenue Stream are secured by all of the Company’s patent assets as of October 1, 2014 and the Cash Collateral Account, in each case junior in priority to the rights of the Note Purchasers. In connection with the Revenue Participants’ right to receive a portion of the Company’s Monetization Revenues, the Company has recorded a net liability of $2,478,057, which represents the fair value of the expected Monetization Revenues, discounted 20% over the expected life of the revenue share agreement. As part of the Fortress Agreement, the Company and the Collateral Agent entered into a Patent License Agreement (the “Patent License Agreement”), under which the Company agreed to grant to the Collateral Agent a non-exclusive, royalty-free, and worldwide license to certain of its Patents (the “Licensed Patents”), which can only be used by the Collateral Agent following an occurrence and during the continuance of an event of default of the Fortress Agreement. When the Fortress Notes (as defined below) and Revenue Stream are paid in full, the Patent License Agreement will terminate. As part of the transaction, the Company granted the Note Purchaser and Revenue Participant a first priority security interest in all of the Company’s patent assets owned as of October 1, 2014 and all proceeds thereof, as well as a general security interest in all of the assets of the Company and its subsidiaries. The Note Purchaser and Revenue Participant do not have a security interest in any future patent purchases by the Company. As part of the transaction, the Company is required to maintain a minimum $ 1,000,000 Effective February 25, 2015, the Company entered into an Amended and Restated Revenue Sharing and Note Purchase Agreement (the “Fortress Amended Agreement” and together with the original Fortress Agreement, sometimes referred to as the “Fortress Agreement”) with Fortress, under which Fortress agreed to make available to the Company up to an additional $ 3,000,000 1,199,500 500,000 72,600 1,126,900 In connection with the issuance of the Additional Notes and the Revenue Participants’ right to receive a portion of the Company’s Monetization Revenues, the Company has recorded a net liability of $ 335,762 18 In addition to the issuance of the Additional Notes, the Fortress Amended Agreement amended the original Fortress Agreement as follows: · · The Additional Notes will be repaid from the future licensing payments on the Draw Down Licenses received from those specific Draw Down licensee(s), while the requirements otherwise to pay 86% of the Monetization Net Revenues towards the Original Notes for (i) the upfront payment of the initial Draw Down License and (ii) the remaining future payments of Draw Down Licenses are waived in general. · · The Company shall not be required to apply the initial installment payment under the first Draw Down License to the Company’s obligations under the Fortress Notes or the Revenue Stream under the Fortress Amended Agreement. In connection with the February 25, 2015 modification to the original Fortress Agreement and Revenue Participants’ right to receive a portion of the Company’s Monetization Revenues, the Company has recorded a loss of $ 2,268,373 The Fortress Agreement also contemplates the issuance of up to an additional $ 2,000,000 Except as described above, the terms of the Additional Notes are identical to the terms of the original Notes issued pursuant to the original Fortress Agreement. Except as described above, the terms of the Original Fortress Agreement, and the Original Notes and warrants issued thereunder, remain in full force in effect, including the existing Monetization Revenue payments for the original Notes and the calculation of the termination fee based on the principal of the Original Notes. Unregistered Sales of Equity Securities. In connection with the execution of the original Fortress Agreement, the Company issued 500,000 2.00 1,000,000 On October 1, 2014, the Company paid the holders of the Amended Secured Convertible Notes and the New Secured Convertible Notes $ 8,000,000 187,351 1,804,030 1,508,162 3,500,000 In connection with the closing of the transactions contemplated by the original Fortress Agreement, the Company paid a closing fee of $ 330,000 5 247,500 2.00 153,759 Expected volatility 60 % Risk free rate 1.62 % Dividend yield 0 % Expected term (in years) 5.00 The assumptions utilized were derived in a similar manner as discussed in Note 7 related to the fair value of stock options. On February 27, 2015, in connection with the execution of the original Fortress Amended Agreement, at closing of the transactions with Fortress, the Company sold 500,000 1.14 40,000 On February 27, 2015, in connection with the closing of the transactions contemplated by the Fortress Amended Agreement, the Company paid a closing fee of $ 35,985 5 26,989 2.00 The warrant issuances on February 27, 2015 meet the requirements to be accounted for as equity with a fair value of $ 172,319 4,960 National Securities Fortress Corporation Expected volatility 60 % 60 % Risk free rate 1.7 % 1.5 % Dividend yield 0 % 0 % Expected term (in years) 5.00 7.00

Stockholders' Equity

Stockholders' Equity	6 Months Ended
	Jun. 30, 2015
Stockholders Equity Note [Abstract]
Stockholders' Equity	7. Stockholders’ Equity Common stock The Company is authorized to issue up to 110,000,000 100,000,000 10,000,000 Series A convertible preferred stock 528,548 Series B convertible preferred stock 2,395,653 Options to purchase common stock 2,213,963 Shares reserved for issuance pursuant to 2014 Stock Plan 499,217 Warrants 1,795,447 Total 7,432,828 On March 31, 2015, the Company entered into a securities purchase agreement (“Purchase Agreement”) with certain investors (the “Purchasers”) pursuant to which the Company sold 4,673,914 0.46 2.15 In connection with the Registered Direct Offering, the Company entered into a placement agent agreement (the “Placement Agent Agreement”) with Ladenburg Thalmann & Co. Inc. (the “Placement Agent”) to act as its exclusive placement agent. Pursuant to the Placement Agent Agreement, the Company paid to the Placement Agent $ 106,000 57,611 0.575 50,000 108,697 In addition, the Placement Agent will also be entitled to a tail fee if, within twelve months after the termination of expiration of the Placement Agent Agreement, the Company sells securities to any investor that was introduced to the Company by the Placement Agent and purchased shares in the Registered Direct Offering. The tail fee will be the same as the placement agent’s fee received by the Placement Agent in the Registered Direct Offering, subject to certain reductions described in the Placement Agent Agreement. In connection with the Registered Direct Offering, the Company entered into a separate waiver agreement with one of its current stockholders pursuant to which the holder waived its right of participation to participate in the Registered Direct Offering (the “Right of Participation”). In consideration for such waiver, the Company paid to the holder $ 35,000 Convertible preferred stock Convertible Original Shares Shares Shares Liquidation Series A-1 $ 0.0100 5,000,000 5,000,000 212,466 $ 195,264 Series A-2 $ 1.6996 1,176,748 1,176,748 161,355 $ 274,239 Series B $ 1,000 2,750 2,750 1,102 $ 1,102,000 During the six months ended June 30, 2015, 2,168,624 167,245 In conjunction with the issuance of Series A-1 Preferred Stock and Series A-2 Preferred Stock, proceeds of $ 4,950,000 3,308,874 1,134,016 0.55 0.96 On December 17, 2013, in contemplation of the Merger, the Company issued 2,750 1,000 700,937 2,750,000 2.66 The Series B Preferred Stock was fair valued in conjunction with the Merger. Consequently, the revaluation did not impact earnings per share. A complete description of the rights, preferences, privileges and restrictions of the Series A Preferred Stock and Series B Preferred Stock are included in the Company’s Fifth Amended and Restated Articles of Incorporation (the “Charter”). The following is a summary of certain rights, privileges, preferences and restrictions: Liquidation preference In the event of any voluntary or involuntary liquidation, dissolution or winding up of the Company, the holders of Series A Preferred Stock are entitled to receive an amount equal to the sum of (i) the greater of (x) the product of (I) $ 0.01 1.6996 In the event of any voluntary or involuntary liquidation, dissolution or winding up of the Company, the holders of Series B Preferred Stock are entitled to receive an amount equal to $ 1,000 pari passu If the assets and funds distributed among the holders of the Preferred Stock are insufficient to permit payment to such holders of the full preferential amount, then the entire assets and funds of the Company legally available for distribution shall be distributed ratably among the holders of the Series A Preferred Stock and Series B Preferred Stock in proportion to the preferential amount each such holder is otherwise entitled to receive. Conversion All shares of Series A Preferred Stock are convertible into common stock at the option of the holder at any time after the date of issuance by dividing the stated value of such preferred shares by $ 0.007073 1.202065 2.00 20,000,000 0.289 Anti-dilution Holders of Series A-1 Preferred Stock are entitled to receive certain shares of common stock if and when the Company issues or sells any shares of common stock for a consideration per share less than a certain threshold price (currently $ 0.289 As a result of the issuance of the Fortress Shares and warrants as discussed in Note 6, and the Registered Direct Offering (as defined above), the conversion price for the Series B Preferred Stock is $ 0.46 Voting rights Holders of the Series A Preferred Stock are entitled to one vote for each share of common stock into which their shares can be converted. Holders of Series B Preferred Stock are entitled to 403.5 votes for each share of Series B Preferred Stock held. Substantial Holder Rights The Certificate of Designations, Preferences and Rights for the Series A Preferred Stock contemplates certain rights for any holder of Series A Preferred Stock that purchased a certain threshold number of shares of Series A Preferred Stock for as long as that holder continued to hold at least twenty percent of shares of Series A Preferred Stock originally purchased (such holders referred to as “Substantial Holders”). During the quarter ended June 30, 2015, there were no longer any Substantial Holders and the rights afforded to such Substantial Holders are no longer in effect. Warrants In January 2014, the Company issued warrants to purchase 238,412 3.04 2.27 348,963 In connection with the Merger, the Company issued warrants to purchase 700,937 2.66 586,238 On November 1, 2014 the Company issued 277,500 2.07 164,196 On February 27, 2015, in connection with the Fortress Amended Agreement, the Company sold 500,000 1.14 26,989 2.00 172,319 4,960 Warrants Remaining Contractual Weighted Average 500,000 6.67 $ 1.14 108,697 4.77 $ 0.46 57,611 4.77 $ 0.58 26,989 4.66 $ 2.00 247,500 4.34 $ 2.00 238,412 3.59 $ 3.04 30,000 2.34 $ 2.66 586,238 1.00 $ 2.66 1,795,447 3.81 $ 1.99

Stock-Based Compensation

Stock-Based Compensation	6 Months Ended
	Jun. 30, 2015
Workers Compensation Discount [Abstract]
Stock-Based Compensation	8. Stock-Based Compensation In November 2013, the Board of Directors authorized the 2013 Stock Plan (such plan has since been adopted by the stockholders of the Company in connection with the Merger and renamed the “Inventergy Global, Inc. 2014 Stock Plan”, the “Plan” or the “2014 Plan”). Under the Plan, the Board of Directors may grant incentive stock awards to employees and directors, and non-statutory stock options to employees, directors and consultants as well as restricted stock. The Plan provides for the grant of stock options, restricted stock, and other stock-related and performance awards that may be settled in cash, stock, or other property. The Board of Directors has reserved 3,605,445 Options and RSAs Outstanding Weighted Average Shares Available Exercise Price Per for Grant Number of Shares Share Balance at December 31, 2014 689,529 2,417,918 $ 2.59 Options Granted (1,908,661) 1,908,661 $ 1.02 Options Forfeited 619,864 (619,864) $ 1.14 Options Expired 60,091 (60,091) $ 2.27 Options Cancelled 1,432,661 (1,432,661) $ 2.73 Restricted Stock Granted (394,267) 394,267 $ 0.39 Restricted Stock Vested - (394,267) $ 0.39 Balance at June 30, 2015 499,217 2,213,963 $ 1.56 Total vested and expected to vest shares (options) 2,213,963 $ 1.56 Total vested shares (options) 948,833 $ 2.33 As of June 30, 2015, all of the restricted stock granted under the plan had vested. The aggregate intrinsic value of stock options outstanding, stock options vested and expected to vest, and exercisable at June 30, 2015 was $ 0 Prior to the plan being established, the Company granted the equivalent of 7,167,585 4,509,238 424,170 As part of the Merger, 15,000 14.30 Cancellation and Issuance of Options On March 25, 2015, the Company cancelled certain unvested options (totaling 1,432,661 2.05 3.85 10 1 4 1,269,845 2.1 3.1 162,816 1.14 48 Options Outstanding Options Vested Weighted- Average Weighted- Weighted- Exercise Remaining Average Average Price Per Shares Contractual Exercise Shares Exercise Share Outstanding Life (Years) Price Exercisable Price Per $ 0.56 25,000 1.84 $ 0.56 25,000 $ 0.56 $ 0.69 326,000 9.58 $ 0.69 - $ - $ 0.77 150,000 9.43 $ 0.77 25,000 $ 0.77 $ 1.14 990,818 8.33 $ 1.14 176,738 $ 1.14 $ 2.05 17,800 9.09 $ 2.05 17,800 $ 2.05 $ 2.27 525,628 8.45 $ 2.27 525,628 $ 2.27 $ 3.04 123,717 1.11 $ 3.04 123,717 $ 3.04 $ 3.85 40,000 7.60 $ 3.85 40,000 $ 3.85 $ 14.30 15,000 0.96 $ 14.30 15,000 $ 14.30 2,213,963 8.08 $ 1.56 948,883 $ 2.33 Stock-based compensation expense 2015 Expected volatility 64 % Risk free rate 1.48 % Dividend yield 0 % Expected term (in years) 6.06 The expected term of the options is based on the average period the stock options are expected to remain outstanding based on the option’s vesting term and contractual terms. The expected stock price volatility assumptions for the Company’s stock options were determined by examining the historical volatilities for industry peers, as the Company did not have any trading history for the Company’s common stock. The risk-free interest rate assumption is based on the U.S. Treasury instruments whose term was consistent with the expected term of the Company’s stock options. The expected dividend assumption is based on the Company’s history and expectation of dividend payouts. Forfeitures were estimated based on the Company’s estimate of future cancellations. For the three months ended June 30 For the six months ended June 30 2015 2014 2015 2014 General and administrative $ 124,627 $ 865,922 $ 596,901 $ 1,861,654 In November 2014, the Company modified the terms to an option granted to a former director. The Company determined that there was no incremental compensation expense associated with the modification. No income tax benefit has been recognized related to stock-based compensation expense and no tax benefits have been realized from exercised stock awards. As of June 30, 2015, there were total unrecognized compensation costs of $ 1,648,911 1.44 Non-employee stock-based compensation expense For the three and six months ended June 30, 2015 and 2014, the Company issued options and restricted stock awards to non-employees in exchange for services with vesting specific to each individual award. Non-employee stock-based compensation expense is recognized as the awards vest and totaled $ 122,659 216,672 594,103 1,380,903

Income Taxes

Income Taxes	6 Months Ended
	Jun. 30, 2015
Income Tax Disclosure [Abstract]
Income Taxes	9. Income Taxes On a quarterly basis, the Company records income tax expense or benefit based on year-to-date results and expected results for the remainder of the year. The Company recorded no provision for income taxes for the three- and six- month periods ended June 30, 2015 and 2014. Deferred income taxes reflect the tax effect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Based on the Company’s historical net losses during its development stage, the Company has provided a full valuation allowance against its deferred tax assets as of June 30, 2015 and 2014. The use of the Company’s net operating loss carryforwards is subject to certain annual limitations and may be subject to further limitations as a result of changes in ownership as defined by the Internal Revenue Code and similar state provisions. Such limitations could result in the expiration of net operating loss carryforwards prior to utilization. The Company files U.S. Federal and state tax returns. As of June 30, 2015 and 2014, all tax years remain open in most jurisdictions. The Company is not currently under examination by income tax authorities in federal or state jurisdictions.

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jun. 30, 2015
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	10. Commitments and Contingencies Operating lease In March 2014, the Company entered into a non-cancelable thirty-eight month lease agreement for offices in Campbell, California commencing June 1, 2014 with escalating rent payments ranging from approximately $ 9,200 9,800 18,993 Years ending December 31: 2015 57,136 2016 116,201 2017 68,587 Total $ 241,924 Rent expense was approximately $ 27,168 20,286 54,320 45,019 Guaranteed payments The Company has entered into agreements to purchase certain patent assets. The Company will be required to pay the remaining future unconditional guaranteed payments of $ 20,000,000 18 12 Years ending December 31: 2015 5,000,000 2016 5,000,000 2017 10,000,000 Less: discount to present value (2,205,558) Guaranteed payments, net of discount $ 17,794,442 Pursuant to the patent purchase agreement with Panasonic Corporation (“Panasonic”), a significant portion of the above guaranteed payments are owed to Panasonic. If the Company’s market capitalization falls below the aggregate dollar amount that the Company owes at that relevant point in time to Panasonic (but only prior to full payment), Panasonic may exercise a limited right to repurchase the Panasonic patent portfolio assets at a purchase price at least equal to the amount the Company paid to purchase the Panasonic patent portfolio. During the three months ended June 30, 2015, the Company was in compliance with the terms of the agreement. Fortress Notes payable Years ending December 31: 2015 1,578,107 2016 6,433,856 2017 4,955,250 Total $ 12,967,213

Summary of Significant Accoun16

Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2015
Accounting Policies [Abstract]
Basis of presentation	Basis of presentation The consolidated financial statements have been prepared on the accrual basis of accounting in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The consolidated financial statements include the accounts of the Company and its subsidiaries. All material intercompany accounts and transactions have been eliminated in consolidation. The accompanying interim financial statements are condensed and should be read in conjunction with the Company’s latest annual financial statements. It is management’s opinion that all adjustments necessary for a fair presentation of the results for the interim periods have been made, and all such adjustments were of a normal recurring nature.
Liquidity and Capital Resources	Liquidity and Capital Resources At June 30, 2015, the Company had an accumulated deficit since inception of $ 49,097,693 3,603,327 August 6, 2015 3,016,667 1,000,000 1,126,900 1,835,000 4,000,000 The business may require significant amounts of capital over the next twelve months to sustain operations and make the investments it needs to continue operations and execute its longer term business plan. We believe that cash required for operating expenses will be approximately $ 6.5 2.4 0.8 0.8 2.5 4.4 2.4 2 Based on our existing cash balances, anticipated revenues from patent monetization activities, proactive measures to reduce expenses and defer obligations where possible, management believes we have funds sufficient to meet our anticipated operating needs for approximately five months. To date, the Company has acquired an aggregate of approximately 755 currently active patents and patent applications for aggregate purchase payments of $ 12,109,118 20 18 17.8 As of June 30, 2015, the Company had cash and cash equivalents of $ 5,449,313 1,000,000 3,603,327 6,024,480 49,097,693 The Company will also require additional financing for the purchase of additional patent portfolios and to fund their monetization efforts if new attractive opportunities are found. If the Company acquires additional large patent portfolios, in addition to the cost of the upfront purchase fee (if any) it is likely that additional resources (business, technical or legal) may need to be hired to effectively monetize the portfolio. Resources to analyze new portfolios are already part of the current staffing of the Company. Litigation costs are based primarily on a contingent fee structure (expected to average less than 20% of license revenue for a portfolio) and as such do not scale significantly with the acquisition of new portfolios.
Management estimates and related risks	Management estimates and related risks The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions about the reported amounts of assets and liabilities, and disclosures of contingent assets and liabilities, at the dates of the financial statements and the reported amounts of revenues and expenses during the reported periods. Although these estimates reflect management's best estimates, it is at least reasonably possible that a material change to these estimates could occur in the near term.
Revenue Recognition	Revenue Recognition Revenue is recognized when (i) persuasive evidence of an arrangement exists, (ii) all obligations have been substantially performed pursuant to the terms of the arrangement, (iii) amounts are fixed or determinable, and (iv) the collectability of amounts is reasonably assured. Licensing Fees We derive revenue primarily from the monetization of acquired patents, either through licensing agreements or outright sales of patents. In general, licensing arrangements provide for the payment of contractually determined fees in consideration for the grant of certain intellectual property rights for patented technologies owned or controlled by the Company. These rights typically include some combination of the following: (i) the grant of a non-exclusive, retroactive and future license to manufacture and/or sell products covered by patented technologies, (ii) a covenant-not-to-litigate, (iii) the release of the licensee from certain claims, and (iv) the dismissal of any pending litigation. The intellectual property rights granted may be perpetual in nature, extending until the expiration of the related patents, or can be granted for a defined period of time, with the licensee possessing the right to renew the agreement at the end of each contractual term for additional payments. The Company recognizes licensing fees when there is persuasive evidence of a licensing arrangement, fees are fixed or determinable, delivery has occurred and collectability is reasonably assured. Patent Sales The Company’s patent monetization efforts also include the sale of select patent assets. As patent sales represents a component of the Company’s ongoing major or central operations and activities, the Company records the related proceeds as revenue. The Company recognizes the patent sales revenue when there is persuasive evidence of a sales arrangement, fees are fixed or determinable, delivery has occurred and collectability is reasonably assured. These requirements are generally fulfilled upon closing of the patent sale transaction. Amounts related to revenue arrangements that do not meet the revenue recognition criteria described above are deferred until the revenue recognition criteria are met. The Company assesses the collectability of fees receivable based on a number of factors, including past transaction history and credit-worthiness of licensees. If it is determined that collection is not reasonably assured, the fee is recognized when collectability becomes reasonably assured, assuming all other revenue recognition criteria have been met.
Cost of Revenues	Cost of Revenues Cost of revenues primarily include the costs of patents sold, and other amounts paid to third parties, including technical consultants and intellectual property counsel, under revenue sharing agreements. These costs are included under the caption “Cost of Revenues” in the accompanying Condensed Consolidated Statement of Operations.
Contingent Legal and Consulting Fees	Contingent Legal and Consulting Fees Contingent legal fees are expensed in the Condensed Consolidated Statement of Operations in the period that such fees are determined to be probable, usually when the related revenues are recognized. In instances where there are no recoveries from potential infringers, no contingent legal and consulting fees are paid; however, the Company may be liable for certain out of pocket legal and consulting costs incurred pursuant to the underlying legal and consulting services agreement. In the three months ended June 30, 2015, the Company discovered certain legal fees had been expensed in prior periods which were contingent in nature and whose probability had not yet been determined. Such fees, which were not material to the individual prior periods, were reversed in the three month period ended June 30, 2015.
Cash and cash equivalents	Cash and cash equivalents The Company considers all highly liquid financial instruments with original maturities of three months or less at the time of purchase to be cash equivalents.
Accounts Receivable	Accounts Receivable Accounts receivable are stated net of allowances for doubtful accounts. The Company typically grants standard credit terms to customers in good credit standing. The Company generally reserves for estimated uncollectible accounts on a customer-by-customer basis, which requires judgment about each individual customer’s ability and intention to fully pay account balances. The Company makes these judgments based on knowledge of and relationships with customers and current economic trends, and updates estimates on a monthly basis. Any changes in estimate, which can be significant, are included in earnings in the period in which the change in estimate occurs. As of June 30, 2015, the Company has not established any reserves for uncollectable accounts.
Inventories	Inventories Inventories consist of finished goods and some component and spare parts. Inventory is valued at the lower of cost or market with cost determined utilizing standard cost which approximates the first-in, first-out (FIFO) method. The Company performs an analysis of slow-moving or obsolete inventory on a regular basis and any changes in valuation reserves, which could potentially be significant, are included in earnings in the period in which the evaluations are completed.
Property and equipment	Property and equipment are recorded at cost less accumulated depreciation and amortization. Depreciation and amortization are computed using the straight-line method over the estimated useful lives of the assets (or the term of the lease, if shorter), which range from three to five years. Routine maintenance and repair costs are expensed as incurred. The costs of major additions, replacements and improvements are capitalized. Upon retirement or sale, the cost of assets disposed and the related accumulated depreciation is removed and any resulting gain or loss is credited or charged to operations.
Patents	Patents Patents, including acquisition costs, are stated at cost, less accumulated amortization. Amortization is computed using the straight-line method over the estimated useful lives of the respective assets, generally 7 10
Intangible Assets	Intangible Assets Intangible assets consist of certain contract rights acquired in the Merger. Intangible assets are amortized on a straight-line basis over their estimated useful life of five years.
Goodwill	Goodwill Goodwill represents the excess of the aggregate purchase price over the fair value of the net tangible and identifiable intangible assets acquired by the Company. The carrying amount of goodwill will be tested for impairment annually or more frequently if facts and circumstances warrant a review. The Company determined that it is a single reporting unit for the purpose of goodwill impairment tests. For purposes of assessing the impairment of goodwill, the Company estimates the value of the reporting unit using its market capitalization as the best evidence of fair value. This fair value is then compared to the carrying value of the reporting unit.
Impairment of long-lived assets	Impairment of long-lived assets The Company evaluates the carrying value of long-lived assets on an annual basis, or more frequently whenever circumstances indicate a long-lived asset may be impaired. When indicators of impairment exist, the Company estimates future undiscounted cash flows attributable to such assets. In the event cash flows are not expected to be sufficient to recover the recorded value of the assets, the assets are written down to their estimated fair value. On December 31, 2014, the Company recorded an impairment charge of $ 686,350
Concentration of credit risk	Concentration of credit risk Financial instruments that potentially subject the Company to a concentration of credit risk consist of cash and cash equivalents. Cash and cash equivalents are deposited with high quality financial institutions. Periodically, such balances are from time to time in excess of federally insured limits.
Stock-based compensation	Stock-based compensation The Company has a stock option plan under which incentive and non-qualified stock options and restricted stock awards (“RSAs”) are granted primarily to employees. All share-based payments to employees, including grants of employee stock options and RSAs, are recognized in the financial statements based on their respective grant date fair values. The benefits of tax deductions in excess of recognized compensation cost are reported as a financing cash flow. The Company estimates the fair value of share-based payment awards on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as expense ratably over the requisite service periods in the Company’s statements of comprehensive income or loss. The Company has estimated the fair value of each option award as of the date of grant using the Black-Scholes option pricing model. The fair value of RSAs is calculated as the fair value of the underlying stock multiplied by the number of shares awarded. The awards issued consist of fully-vested stock awards, performance-based restricted shares, and service-based restricted shares. Expenses related to stock-based awards issued to non-employees are recognized at fair value on a recurring basis in the periods those awards are expected to vest. The Company estimates the fair value of the awards using the Black-Scholes option pricing model.
Income taxes	Income taxes The Company accounts for income taxes using the asset and liability method whereby deferred tax asset and liability account balances are determined based on temporary differences between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to affect taxable income. A valuation allowance is established when it is more likely than not that deferred tax assets will not be realized. Realization of deferred tax assets is dependent upon future pretax earnings, the reversal of temporary differences between book and tax income, and the expected tax rates in future periods. The Company has a full valuation allowance on all deferred tax assets. The Company is required to evaluate the tax positions taken in the course of preparing its tax returns to determine whether tax positions are “more-likely-than-not” of being sustained by the applicable tax authority. Tax benefits of positions not deemed to meet the more-likely-than-not threshold would be recorded as a tax expense in the current year. The amount recognized is subject to estimate and management judgment with respect to the likely outcome of each uncertain tax position. The amount that is ultimately sustained for an individual uncertain tax position or for all uncertain tax positions in the aggregate could differ from the amount that is initially recognized.
Fair value measurements	Fair value measurements The Company defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs within the fair value hierarchy. Observable inputs are inputs that market participants would use in pricing the asset or liability developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company’s own assumptions about what market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. The following methods and assumptions were used to estimate the fair value of financial instruments: ⋅ Level 1 - Valuation is based upon quoted prices for identical instruments traded in active markets. ⋅ Level 2 - Valuation is based upon quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market. ⋅ Level 3 - Valuation is generated from model-based techniques that use significant assumptions not observable in the market. These unobservable assumptions reflect management’s estimates of assumptions that market participants would use in pricing the asset or liability. Valuation techniques include use of option pricing models, discounted cash flow models and similar techniques. The category within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement.
Recently Issued Accounting Standards	Recently Issued Accounting Standards In May 2014, the FASB issued a new financial accounting standard which outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes current revenue recognition guidance. ASU 2014-09 Revenue from Contracts with Customers is effective for annual reporting periods (including interim reporting periods within those periods) beginning after December 15, 2017. Early adoption is not permitted. We are currently evaluating the impact of this accounting standard. In June 2014, the FASB issued Accounting Standards Update (“ASU”) ASU 2014-10 Development Stage Entities. The amendments in ASU 2014-10 remove the definition of a development stage entity from Topic 915 Development Stage Entities, thereby removing the distinction between development stage entities and other reporting entities from US GAAP. In addition, the amendments eliminate the requirements for development stage entities to (1) present inception-to-date information in the statements of operations, cash flows, and shareholder’s equity, (2) label the financial statements as those of a development stage entity, (3) disclose a description of the development stage activities in which the entity is engaged, and (4) disclose in the first year in which the entity is no longer a development stage entity that in prior years it had been in the development stage. The amendments also clarify that the guidance in Topic 275, Risks and Uncertainties, is applicable to entities that have not commenced planned principal operations. ASU 2014-10 is effective for annual reporting periods beginning after December 15, 2014, and interim periods therein. The Company could early adopt ASU 2014-10 for any annual reporting period or interim period for which the entity’s financial statements have not yet been issued. The Company elected to adopt this ASU beginning with the June 30, 2014 Quarterly Report on Form 10-Q and its adoption resulted in the removal of inception-to-date information in the Company’s statements of operations and cash flows. In August 2014, the FASB issued a new accounting standard which requires management to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern for each annual and interim reporting period and to provide related footnote disclosures in certain circumstances. ASU 2014-15 Presentation of Financial Statements - Going Concern is effective for annual reporting periods (including interim reporting periods within those periods) beginning after December 15, 2016. Early adoption is permitted. We are currently evaluating the impact of this accounting standard. In April 2015, the FASB issued a new accounting standard which changes the presentation of debt issuance costs in financial statements. Under the new standard, an entity presents such costs in the balance sheet as a direct deduction from the related debt liability rather than as an asset. Amortization of the costs is reported as interest expense. The accounting standard is effective for annual reporting periods beginning after December 15, 2015 and interim periods beginning after December 15, 2016. Early adoption is allowed for all entities for financial statements that have not been previously issued. The adoption of this standard is not expected to have a material impact on the Company’s consolidated financial statements.

Business Combination (Tables)

Business Combination (Tables)	6 Months Ended
	Jun. 30, 2015
Business Combinations [Abstract]
Purchase price allocation	The total purchase consideration and the purchase price allocation were as follows: Fair value of assumed equity allocated to purchase consideration $ 10,985,867 Total purchase consideration $ 10,985,867 Goodwill $ 8,858,504 Intangible asset contract rights 1,342,000 Other assets acquired 816,045 Liabilities assumed (30,682) Total purchase allocation $ 10,985,867

Patents (Tables)

Patents (Tables)	6 Months Ended
	Jun. 30, 2015
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Finite-Lived Intangible Assets	Patent intangible assets consist of the following at June 30, 2015: Weighted Average Gross Carrying Accumulated Net Carrying Useful Life Amount Amortization Amount Amortizable intangible assets: Patents 8.0 $ 11,893,745 $ (2,468,336) $ 9,425,409 Total patent intangible assets $ 11,893,745 $ (2,468,336) $ 9,425,409

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended
	Jun. 30, 2015
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis	The following tables summarize the Company's assets and liabilities measured at fair value on a recurring basis at June 30, 2015 and December 31, 2014: June 30, 2015 Fair Value (Level 1) (Level 2) (Level 3) Common stock warrants $ 59,262 $ - $ - $ 59,262 Total $ 59,262 $ - $ - $ 59,262 December 31, 2014 Fair Value (Level 1) (Level 2) (Level 3) Common stock warrants $ 30,278 $ - $ - $ 30,278 Total $ 30,278 $ - $ - $ 30,278
Schedule Of Changes In Fair Value Derivative Liability	The fair value of the derivative liability as of June 30, 2015 was estimated using the following assumptions: Expected volatility 60 % Risk free rate 1.05 % Dividend yield 0 % Expected term (in years) 3.8226
Schedule of Changes in Fair Value of Company's Level 3 Liabilities	The following sets forth a summary of changes in fair value of the Company’s level 3 liabilities measured on a recurring basis for the six months ended June 30, 2014 and June 30, 2015: Series A-1 Convertible Preferred Common Notes Payable Stock Stock Derivative Liability Derivative Liability Warrants Balance at December 31, 2013 $ 534,975 $ 56,926 $ - Extinguishment (118,300) - - Fair value at issuance 189,300 - 466,706 Change in fair value (220,975) (56,926) (117,743) Balance at June 30, 2014 $ 385,000 $ - $ 348,963 Series A-1 Convertible Preferred Common Notes Payable Stock Stock Derivative Liability Derivative Liability Warrants Balance at December 31, 2014 $ - $ - $ 30,278 Fair value at issuance - - 41,305 Change in fair value - - (12,321) Balance at June 30, 2015 $ - $ - $ 59,262

Borrowing Arrangements (Tables)

Borrowing Arrangements (Tables)	6 Months Ended
	Jun. 30, 2015
Debt Disclosure [Abstract]
Schedule of warrant fair value assumptions	The fair value of the warrant as of November 1, 2014 was estimated using the following assumptions: Expected volatility 60 % Risk free rate 1.62 % Dividend yield 0 % Expected term (in years) 5.00
Schedule of equity warrant fair value assumptions	The fair value of the issued warrants as of February 27, 2015, were estimated using the following assumptions: National Securities Fortress Corporation Expected volatility 60 % 60 % Risk free rate 1.7 % 1.5 % Dividend yield 0 % 0 % Expected term (in years) 5.00 7.00

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	6 Months Ended
	Jun. 30, 2015
Stockholders Equity Note [Abstract]
Shares of common stock reserved for future issuance	Shares of common stock reserved for future issuance were as follows as of June 30, 2015: Series A convertible preferred stock 528,548 Series B convertible preferred stock 2,395,653 Options to purchase common stock 2,213,963 Shares reserved for issuance pursuant to 2014 Stock Plan 499,217 Warrants 1,795,447 Total 7,432,828
Redeemable Convertible preferred stock	Convertible preferred stock as of June 30, 2015 consisted of the following: Convertible Original Shares Shares Shares Liquidation Series A-1 $ 0.0100 5,000,000 5,000,000 212,466 $ 195,264 Series A-2 $ 1.6996 1,176,748 1,176,748 161,355 $ 274,239 Series B $ 1,000 2,750 2,750 1,102 $ 1,102,000
Common stock warrants	Common stock warrants outstanding as of June 30, 2015 are listed as follows: Warrants Remaining Contractual Weighted Average 500,000 6.67 $ 1.14 108,697 4.77 $ 0.46 57,611 4.77 $ 0.58 26,989 4.66 $ 2.00 247,500 4.34 $ 2.00 238,412 3.59 $ 3.04 30,000 2.34 $ 2.66 586,238 1.00 $ 2.66 1,795,447 3.81 $ 1.99

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	6 Months Ended
	Jun. 30, 2015
Workers Compensation Discount [Abstract]
Summary of share-based compensation activity	Common stock option and restricted stock award activity under the Plan was as follows: Options and RSAs Outstanding Weighted Average Shares Available Exercise Price Per for Grant Number of Shares Share Balance at December 31, 2014 689,529 2,417,918 $ 2.59 Options Granted (1,908,661) 1,908,661 $ 1.02 Options Forfeited 619,864 (619,864) $ 1.14 Options Expired 60,091 (60,091) $ 2.27 Options Cancelled 1,432,661 (1,432,661) $ 2.73 Restricted Stock Granted (394,267) 394,267 $ 0.39 Restricted Stock Vested - (394,267) $ 0.39 Balance at June 30, 2015 499,217 2,213,963 $ 1.56 Total vested and expected to vest shares (options) 2,213,963 $ 1.56 Total vested shares (options) 948,833 $ 2.33
Outstanding options	The following table summarizes information with respect to stock options outstanding at June 30, 2015: Options Outstanding Options Vested Weighted- Average Weighted- Weighted- Exercise Remaining Average Average Price Per Shares Contractual Exercise Shares Exercise Share Outstanding Life (Years) Price Exercisable Price Per $ 0.56 25,000 1.84 $ 0.56 25,000 $ 0.56 $ 0.69 326,000 9.58 $ 0.69 - $ - $ 0.77 150,000 9.43 $ 0.77 25,000 $ 0.77 $ 1.14 990,818 8.33 $ 1.14 176,738 $ 1.14 $ 2.05 17,800 9.09 $ 2.05 17,800 $ 2.05 $ 2.27 525,628 8.45 $ 2.27 525,628 $ 2.27 $ 3.04 123,717 1.11 $ 3.04 123,717 $ 3.04 $ 3.85 40,000 7.60 $ 3.85 40,000 $ 3.85 $ 14.30 15,000 0.96 $ 14.30 15,000 $ 14.30 2,213,963 8.08 $ 1.56 948,883 $ 2.33
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions	The fair value of employee stock options granted was estimated using the following weighted-average assumptions for the six months ended June 30, 2015: 2015 Expected volatility 64 % Risk free rate 1.48 % Dividend yield 0 % Expected term (in years) 6.06
Schedule Of Stock Based Compensation Of Employees And Non Employees	Stock-based compensation for employees and non-employees related to options and RSAs recognized: For the three months ended June 30 For the six months ended June 30 2015 2014 2015 2014 General and administrative $ 124,627 $ 865,922 $ 596,901 $ 1,861,654

Commitments and Contingencies (

Commitments and Contingencies (Tables)	6 Months Ended
	Jun. 30, 2015
Commitments and Contingencies Disclosure [Abstract]
Future minimum annual lease payments	The future minimum payments related to this lease are as follows: Years ending December 31: 2015 57,136 2016 116,201 2017 68,587 Total $ 241,924
Future guaranteed payments	Future guaranteed payments associated with these agreements are payable as follows: Years ending December 31: 2015 5,000,000 2016 5,000,000 2017 10,000,000 Less: discount to present value (2,205,558) Guaranteed payments, net of discount $ 17,794,442
Notes payable future debt payments	Pursuant to the Fortress Agreement (as described in Note 6), future debt payments owed to Fortress with respect to the Fortress Notes are as follows: Years ending December 31: 2015 1,578,107 2016 6,433,856 2017 4,955,250 Total $ 12,967,213

Summary of Significant Accoun24

Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($)	1 Months Ended		3 Months Ended		6 Months Ended		12 Months Ended	32 Months Ended
	Apr. 30, 2015	Oct. 01, 2014	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014	Dec. 31, 2014	Aug. 31, 2017	Aug. 06, 2015	Jun. 06, 2014	Dec. 31, 2013
Summary of Significant Accounting Policies [Line Items]
Cash and Cash Equivalents, at Carrying Value, Total			$ 5,449,313	$ 484,175	$ 5,449,313	$ 484,175	$ 1,443,349				$ 1,518,684
Working Capital Net Amount			3,603,327		3,603,327
Net Income (Loss) Attributable to Parent, Total			601,353	$ (3,932,313)	(6,024,480)	(9,397,627)
Retained Earnings (Accumulated Deficit), Total			(49,097,693)		(49,097,693)		(43,073,213)
Debt Instrument, Face Amount			4,400,000		4,400,000					$ 300,000
Asset Impairment Charges							$ 686,350
Proceeds from Lines of Credit					1,126,900
Finite-Lived Intangible Assets, Gross			11,893,745		11,893,745
Guaranteed Benefit Liability, Net			17,794,442		17,794,442
Future Unconditional Guarantee Paid					20,000,000
Additional Working Capital			6,500,000		6,500,000
Employee-related Liabilities, Current			2,400,000		2,400,000
Maintenance Costs					800,000
Other Cost and Expense, Operating					$ 2,500,000
Contingent Fee Description					Litigation costs are based primarily on a contingent fee structure (expected to average less than 20% of license revenue for a portfolio) and as such do not scale significantly with the acquisition of new portfolios.
Cash Reserves			1,000,000		$ 1,000,000
Litigation Settlement, Expense					800,000
Proceeds from Issuance of Common Stock	$ 1,835,000				1,835,000	$ 6,487,850
Proceeds from Sale of Intangible Assets					4,000,000
Debt Instrument, Periodic Payment, Interest					2,400,000
Repayments of Debt					2,000,000
Fortress Agreement [Member]
Summary of Significant Accounting Policies [Line Items]
Working Capital Net Amount			3,603,327		3,603,327
Retained Earnings (Accumulated Deficit), Total			49,097,693		49,097,693
Payments for Fees		$ 385,000
Cash Reserves			1,000,000		1,000,000
Subsequent Event [Member]
Summary of Significant Accounting Policies [Line Items]
Future Unconditional Guarantee Paid								$ 20,000,000
Cash									$ 3,016,667
Patents [Member]
Summary of Significant Accounting Policies [Line Items]
Finite-Lived Intangible Assets, Gross			$ 11,893,745		$ 11,893,745
Patents [Member] | Subsequent Event [Member]
Summary of Significant Accounting Policies [Line Items]
Payments for Fees								$ 18,000,000
Minimum [Member] | Patents [Member]
Summary of Significant Accounting Policies [Line Items]
Property plant and equipments estimated useful lives of assets					7 years
Maximum [Member] | Patents [Member]
Summary of Significant Accounting Policies [Line Items]
Property plant and equipments estimated useful lives of assets					10 years

Business Combination - Addition

Business Combination - Additional Information (Detail)	1 Months Ended	6 Months Ended	12 Months Ended
	Jun. 06, 2014USD ($)shares	Jun. 30, 2015USD ($)shares	Dec. 31, 2014USD ($)shares
Business Acquisition [Line Items]
Stockholders' equity note, stock split, conversion ratio		1.4139
Common Stock, Shares, Issued	20,018,028	36,518,792	27,997,128
Common Stock, Shares, Outstanding	20,018,028	36,518,792	27,997,128
Class of Warrant or Right, Outstanding	700,937
Initial Amount Of Contingent Note | $	$ 11,000,000
Debt Instrument, Face Amount | $	$ 300,000	$ 4,400,000
Business Acquisition, Goodwill, Expected Tax Deductible Amount | $		8,858,504
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill | $		$ 1,342,000
Finite-Lived Intangible Asset, Useful Life		5 years
Business Combination, Acquisition Related Costs | $		$ 1,237,641
Asset Impairment Charges | $			$ 686,350
Series A Preferred Stock [Member]
Business Acquisition [Line Items]
Preferred Stock, Shares Issued	6,176,748
Preferred Stock, Shares Outstanding	6,176,748
Preferred Class B [Member]
Business Acquisition [Line Items]
Preferred Stock, Shares Issued	2,231
Preferred Stock, Shares Outstanding	2,231
Placement Agents [Member]
Business Acquisition [Line Items]
Class of Warrant or Right, Outstanding	238,412

Purchase Consideration And Purc

Purchase Consideration And Purchase Price Allocation (Detail) - Jun. 30, 2015 - USD ($)	Total
Purchase Price Allocation [Line Items]
Fair value of assumed equity allocated to purchase consideration	$ 10,985,867
Total purchase consideration	10,985,867
Goodwill	8,858,504
Intangible asset contract rights	1,342,000
Other assets acquired	816,045
Liabilities assumed	(30,682)
Total purchase allocation	$ 10,985,867

Patents - Additional Informatio

Patents - Additional Information (Detail)	6 Months Ended
	Jun. 30, 2015USD ($)
Expected Amortization Expense of Intangible Assets for Each of Next Six Years	$ 1,510,977

Patent Intangible Assets (Detai

Patent Intangible Assets (Detail) - USD ($)	6 Months Ended
	Jun. 30, 2015	Dec. 31, 2014
Weighted Average Useful Life	5 years
Gross Carrying Amount	$ 11,893,745
Accumulated Amortization	(2,468,336)
Net Carrying Amount	$ 9,425,409	$ 10,415,404
Patents [Member]
Weighted Average Useful Life	8 years
Gross Carrying Amount	$ 11,893,745
Accumulated Amortization	(2,468,336)
Net Carrying Amount	$ 9,425,409

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Detail) - USD ($)	6 Months Ended
	Jun. 30, 2015	Oct. 31, 2014	Jan. 31, 2014	Dec. 17, 2013
Fair Value Disclosure [Line Items]
Purchase of warrants to common stock			$ 238,412
Class of Warrant or Right, Exercise Price of Warrants or Rights			$ 3.04	$ 2.66
Debt Instrument, Debt Default, Amount	$ 5,000,000
Debt Conversion, Converted Instrument, Amount	$ 3,000,000
Minimum [Member]
Fair Value Disclosure [Line Items]
Class of Warrant or Right, Exercise Price of Warrants or Rights		$ 2.27
Series A Preferred Stock [Member]
Fair Value Disclosure [Line Items]
Debt instrument convertible threshold stock price	$ 0.289

Fair Value Assets And Liabiliti

Fair Value Assets And Liabilities Measured On Recurring Basis (Detail) - USD ($)	Jun. 30, 2015	Dec. 31, 2014
Liabilities Measured on Recurring Basis [Line Items]
Financial Liabilities Fair Value Disclosure, Total	$ 59,262	$ 30,278
Common stock warrants [Member]
Liabilities Measured on Recurring Basis [Line Items]
Financial Liabilities Fair Value Disclosure, Total	59,262	30,278
Fair Value, Inputs, Level 1 [Member]
Liabilities Measured on Recurring Basis [Line Items]
Financial Liabilities Fair Value Disclosure, Total	0	0
Fair Value, Inputs, Level 1 [Member] | Common stock warrants [Member]
Liabilities Measured on Recurring Basis [Line Items]
Financial Liabilities Fair Value Disclosure, Total	0	0
Fair Value, Inputs, Level 2 [Member]
Liabilities Measured on Recurring Basis [Line Items]
Financial Liabilities Fair Value Disclosure, Total	0	0
Fair Value, Inputs, Level 2 [Member] | Common stock warrants [Member]
Liabilities Measured on Recurring Basis [Line Items]
Financial Liabilities Fair Value Disclosure, Total	0	0
Fair Value, Inputs, Level 3 [Member]
Liabilities Measured on Recurring Basis [Line Items]
Financial Liabilities Fair Value Disclosure, Total	59,262	30,278
Fair Value, Inputs, Level 3 [Member] | Common stock warrants [Member]
Liabilities Measured on Recurring Basis [Line Items]
Financial Liabilities Fair Value Disclosure, Total	$ 59,262	$ 30,278

Estimated Fair Value Of Derivat

Estimated Fair Value Of Derivative Liability (Detail) - 6 months ended Jun. 30, 2015	Total
Fair Value Of Derivative Liability [Line Items]
Expected volatility	60.00%
Risk free rate	1.05%
Dividend yield	0.00%
Expected term (in years)	3 years 9 months 26 days

Summary of Changes in Fair Valu

Summary of Changes in Fair Value of Company's Level 3 Liabilities Measured on Recurring Basis (Detail) - USD ($)	6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
Convertible Notes Payable [Member]
Fair Value Disclosure [Line Items]
Balance beginning	$ 0	$ 534,975
Extinguishment		(118,300)
Fair value at issuance	0	189,300
Change in fair value	0	(220,975)
Balance ending	0	385,000
Series A Preferred Stock [Member]
Fair Value Disclosure [Line Items]
Balance beginning	0	56,926
Extinguishment		0
Fair value at issuance	0	0
Change in fair value	0	(56,926)
Balance ending	0	0
Common stock warrants [Member]
Fair Value Disclosure [Line Items]
Balance beginning	30,278	0
Extinguishment		0
Fair value at issuance	41,305	466,706
Change in fair value	(12,321)	(117,743)
Balance ending	$ 59,262	$ 348,963

Borrowing Arrangements - Additi

Borrowing Arrangements - Additional Information (Detail) - USD ($)	1 Months Ended					3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 26, 2015	Feb. 27, 2015	Feb. 25, 2015	Oct. 01, 2014	Sep. 23, 2014	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014	Dec. 31, 2014	Jun. 06, 2014
Borrowing Arrangements [Line Items]
Debt Instrument, Face Amount						$ 4,400,000		$ 4,400,000			$ 300,000
Gains (Losses) on Extinguishment of Debt, Total						$ 0	$ 0	$ (2,268,373)	$ (2,403,193)
Debt Conversion, Converted Instrument, Shares Issued				1,804,030						1,508,162
Debt Instrument, Description of Variable Rate Basis								LIBOR plus 7%. In addition, a 3% per annum paid-in-kind (PIK) interest will be paid by increasing the principal amount of the Original Notes by the amount of such interest.
Proceeds from Notes Payable								$ 1,126,900	$ 0
National Securities Corporation [Member]
Borrowing Arrangements [Line Items]
Share Price		$ 2		$ 2
Warrants Exercisable Term		5 years		5 years
Debt Instrument, Fee Amount		$ 35,985		$ 330,000
Warrants Not Settleable in Cash, Fair Value Disclosure		$ 4,960		$ 153,759
Stock Issued During Period, Shares, New Issues		26,989		247,500
Fortress Agreement [Member]
Borrowing Arrangements [Line Items]
Proceeds from Issuance of Senior Long-term Debt				$ 9,964,868
Debt Instrument, Redemption Price, Percentage				5.00%
Stock Issued During Period, Value, Issued for Services				$ 1,000,000
Share Price		$ 1.14
Termination Fee Payable				770,000
Gross Proceeds From Senior Long Term Debt				$ 11,000,000
Contract Claims Description				the Company is required to apply, towards its obligations pursuant to the Original Notes, 86% of the difference between (a) any revenues generated from the Monetization Revenue less (b) any litigation or licensing related third party expenses (including fees paid to the original patent owners) reasonably incurred by the Company to earn Monetization Revenue, subject to certain limits (such difference defined as Monetization Net Revenues). If Monetization Net Revenue is applied to outstanding principal of the Original Notes (defined as Mandatory Prepayments), such Mandatory Prepayments are not subject to the prepayment premium described above. To the extent that any obligations under the Original Notes are past due, including if such payments are past due as a result of the acceleration of the Original Notes or certain conditions of breach or alleged breach have occurred, the percentage will increase from 86% to 100%.
Payments for Fees				$ 385,000
Revenue Recognition Under Agreement Description				the Company granted to the purchasers identified in the Fortress Agreement (Revenue Participants) a right to receive a portion of the Companys Monetization Revenues totaling $5,500,000 (unless the Revenue Participants have not received $5,500,000 by the Maturity Date, in which case the Revenue Participants have a right to receive a portion of Monetization Revenues totaling $8,250,000) (the Revenue Stream).
Revenue Recognition of Participants Under Proportionate Share Agreement Description				The Revenue Participants will not receive any portion of the Revenue Stream until all obligations under the Original Notes are paid in full. Following payment in full of the Original Notes, the Company will pay to the Revenue Participants their proportionate share of the Monetization Net Revenues. The Revenue Participants proportionate share is equal to (a) 46% of Monetization Net Revenues until $2,750,000 has been paid to the Revenue Participants, (b) 31% of Monetization Net Revenues until the next $2,750,000 has been paid to the Revenue Participants and (c) 6% of Monetization Net Revenues until the next $2,750,000 has been paid to the Revenue Participants if (a) and (b) have not been fully paid by the Maturity Date. All Revenue Stream Payments will be payable on a monthly basis in arrears. The rights of the Revenue Participants to the Revenue Stream are secured by all of the Companys patent assets as of October 1, 2014 and the Cash Collateral Account, in each case junior in priority to the rights of the Note Purchasers. In connection with the Revenue Participants right to receive a portion of the Companys Monetization Revenues, the Company has recorded a net liability of $2,478,057, which represents the fair value of the expected Monetization Revenues, discounted 20% over the expected life of the revenue share agreement.
Proceeds from Issuance of Debt				$ 450,253
Warrants To Purchase Common Stock		500,000
Warrants Exercisable Term		7 years
Proceeds from Issuance of Warrants		$ 40,000
Warrants Not Settleable in Cash, Fair Value Disclosure		$ 172,319
Fortress Agreement [Member] | Common Stock [Member]
Borrowing Arrangements [Line Items]
Share Price				$ 2
Stock Issued During Period, Shares, New Issues				500,000
Stock Issued During Period, Value, New Issues				$ 1,000,000
Share Purchase Agreement [Member]
Borrowing Arrangements [Line Items]
Share Price	$ 0.46					$ 0.46		$ 0.46
Stock Issued During Period, Value, Other					$ 6,000,000
Proceeds from Issuance or Sale of Equity						$ 100,000
Stock Issued During Period, Shares, New Issues	217,392
Additional Available Credit [Member] | Fortress Agreement [Member]
Borrowing Arrangements [Line Items]
Revenue Recognition of Participants Under Proportionate Share Agreement Description		The Revenue Participants are entitled to receive $7,700,000 (adjusted from the terms of the Original Notes) plus 70% of the Additional Notes as a portion of the Revenue Stream Basis (as defined below) if the Notes and Revenue Stream payments are paid in full by the Maturity Date or $9,350,000 (adjusted from the terms of the Original Notes) plus 85% of the Additional Notes as a portion of the Revenue Stream Basis if the Fortress Notes and Revenue Stream payments are not paid in full by the Maturity Date. The Revenue Stream payments will begin after all obligations on the Fortress Notes are paid in full. The Company is required to apply specified decreasing percentages (46% to 31% to 6%) of its net revenues (net of monetization costs) from monetizing its intellectual property assets on an ongoing basis to meet the Revenue Stream payment obligations. Payment of the full Revenue Stream payments in addition to the Fortress Note obligations by the Maturity Date would ordinarily occur after the Company receives approximately $60,000,000 in gross licensing revenues, assuming an average monetization cost of 33%.
Line of Credit Facility, Remaining Borrowing Capacity			$ 3,000,000
Debt Instrument Percentage Of Monetization Of Net Revenue			0.00%
Proceeds from Notes Payable			$ 1,199,500
Warrants To Purchase Common Stock			500,000
Proceeds from Issuance or Sale of Equity			$ 1,126,900
Payments of Stock Issuance Costs			72,600
Derivative Liability, Fair Value, Amount Not Offset Against Collateral			335,762
Debt Instrument, Fee		The structuring fee equal to 3.5% of the original principal amount of any such Additional Notes is waived.
Monetization Of Revenue Loss From Change In Fair Value			2,268,373
Line Of Credit Facility Additional Borrowing Capacity			$ 2,000,000
Joseph W. Beyers [Member] | Share Purchase Agreement [Member]
Borrowing Arrangements [Line Items]
Share Price					$ 2.14
Stock Issued During Period, Shares, Other					233,640
Stock Issued During Period, Value, Other					$ 500,000
Proceeds from Related Party Debt					300,000			$ 200,000
Due to Related Parties					$ 300,000
First Republic Bank [Member]
Borrowing Arrangements [Line Items]
Debt Instrument, Face Amount				500,000
Convertible Notes Payable [Member]
Borrowing Arrangements [Line Items]
Debt Conversion Original Debt Interest Amount				187,351
Debt Conversion, Original Debt, Amount				8,000,000
Debt Instrument, Collateral Amount				$ 3,500,000
Common Stock, Conversion Features				the right to convert the existing notes into 1,508,162 shares of common stock of the Company until July 2018)

Borrowing Arrangements (Detail)

Borrowing Arrangements (Detail) - Warrant [Member]	1 Months Ended
	Feb. 27, 2015	Nov. 01, 2014
Share-based Goods and Nonemployee Services Transaction [Line Items]
Expected volatility		60.00%
Risk free rate		1.62%
Dividend yield		0.00%
Expected term (in years)		5 years
Fortress Agreement [Member]
Share-based Goods and Nonemployee Services Transaction [Line Items]
Expected volatility	60.00%
Risk free rate	1.70%
Dividend yield	0.00%
Expected term (in years)	5 years
National Securities Corporation [Member]
Share-based Goods and Nonemployee Services Transaction [Line Items]
Expected volatility	60.00%
Risk free rate	1.50%
Dividend yield	0.00%
Expected term (in years)	7 years

Stockholders' Equity - Addition

Stockholders' Equity - Additional Information (Detail) - USD ($)	Nov. 01, 2014	Apr. 30, 2015	Mar. 31, 2015	Feb. 27, 2015	Jan. 31, 2014	Dec. 17, 2013	Jun. 30, 2015	Jun. 30, 2014	Dec. 31, 2014	Oct. 31, 2014	Jun. 06, 2014
Class of Stock [Line Items]
Common stock, par value							$ 0.001		$ 0.001
Common Stock, Shares Authorized							100,000,000		100,000,000
Preferred Stock, Shares Authorized							10,000,000		10,000,000
Class of Warrant or Right, Exercise Price of Warrants or Rights					$ 3.04	$ 2.66
Warrants To Purchase Shares Of Common Stock						700,937
Preferred Stock, Par or Stated Value Per Share							$ 0.001		$ 0.001
Proceeds from Issuance of Private Placement						$ 2,750,000
Proceeds from Issuance of Common Stock		$ 1,835,000					$ 1,835,000	$ 6,487,850
Cash Paid To Holder For Waiver							$ 35,000
Class of Warrant or Right, Outstanding											700,937
Ladenburg Thalmann Co. Inc [Member]
Class of Stock [Line Items]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights							57,611
Class of Warrant or Right, Exercise Price of Warrants or Rights							$ 0.575
Cash Paid To Placement Agent							$ 106,000
Additional Cash paid to Placement Agent							$ 50,000
Additional Class Of Warrant Or Right Issued							108,697
Purchase Agreement [Member]
Class of Stock [Line Items]
Sale of Stock, Price Per Share			$ 0.46
Proceeds from Issuance of Common Stock			$ 2,150,000
Stock Issued During Period, Shares, New Issues			4,673,914
Warrant [Member]
Class of Stock [Line Items]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights					238,412
Fair Value Adjustment of Warrants	$ 164,196				$ 348,963
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 2.07				$ 3.04		$ 2.66
Class of Warrant or Right, Date from which Warrants or Rights Exercisable					Jan. 31, 2019	Jun. 30, 2016	Jun. 30, 2016
Warrants To Purchase Shares Of Common Stock	277,500						700,937
Class of Warrant or Right, Outstanding							586,238
Warrant [Member] | Fortress Agreement [Member]
Class of Stock [Line Items]
Class of Warrant or Right, Exercise Price of Warrants or Rights					$ 2.27
Warrant Two [Member]
Class of Stock [Line Items]
Fair Value Adjustment of Warrants				$ 4,960
Class of Warrant or Right, Exercise Price of Warrants or Rights				$ 2
Warrants To Purchase Shares Of Common Stock				26,989
Warrant One [Member]
Class of Stock [Line Items]
Fair Value Adjustment of Warrants				$ 172,319
Class of Warrant or Right, Exercise Price of Warrants or Rights				$ 1.14
Warrants To Purchase Shares Of Common Stock				500,000
Preferred Stock Series A-1 [Member]
Class of Stock [Line Items]
Common stock, par value							$ 0.007073
Proceeds from Issuance of Convertible Preferred Stock							$ 3,308,874
Temporary Equity, Redemption Price Per Share							$ 0.55
Temporary Equity, Liquidation Preference Per Share							0.01
Debt Instrument Convertible Threshold Stock Price							$ 0.289
Conversion of Stock, Shares Converted							2,168,624
Preferred Stock Series A-2 [Member]
Class of Stock [Line Items]
Common stock, par value							$ 1.202065
Proceeds from Issuance of Convertible Preferred Stock							$ 1,134,016
Temporary Equity, Redemption Price Per Share							$ 0.96
Temporary Equity, Liquidation Preference Per Share							$ 1.6996
Redeemable Convertible Preferred Stock [Member]
Class of Stock [Line Items]
Proceeds from Issuance of Convertible Preferred Stock							$ 4,950,000
Series B Preferred Stock [Member]
Class of Stock [Line Items]
Common stock, par value							$ 1,000
Preferred Stock, Shares Issued						2,750
Preferred Stock, Par or Stated Value Per Share						$ 1,000
Debt Instrument, Convertible, Conversion Price							2
Series A Preferred Stock [Member]
Class of Stock [Line Items]
Preferred Stock, Shares Issued											6,176,748
Debt Instrument Convertible Threshold Stock Price							$ 0.289
Proceeds from Issuance of Common Stock							$ 20,000,000
Series A-2 redeemable convertible preferred stock [Member]
Class of Stock [Line Items]
Conversion of Stock, Shares Converted							167,245
Maximum [Member]
Class of Stock [Line Items]
Common Stock, Shares Authorized							110,000,000
Minimum [Member]
Class of Stock [Line Items]
Class of Warrant or Right, Exercise Price of Warrants or Rights										$ 2.27
Minimum [Member] | Series B Preferred Stock [Member]
Class of Stock [Line Items]
Debt Instrument, Convertible, Conversion Price							$ 0.46

Shares of Common Stock Reserved

Shares of Common Stock Reserved for Future Issuance (Detail)	Jun. 30, 2015shares
Shares Of Common Stock Reserved For Future Issuance [Line Items]
Options to purchase common stock	2,213,963
Shares reserved for issuance	7,432,828
Warrants
Shares Of Common Stock Reserved For Future Issuance [Line Items]
Shares reserved for issuance	1,795,447
2014 Stock Plan
Shares Of Common Stock Reserved For Future Issuance [Line Items]
Shares reserved for issuance	499,217
Series A Convertible Preferred Stock [Member]
Shares Of Common Stock Reserved For Future Issuance [Line Items]
Convertible preferred stock	528,548
Series B Convertible Preferred Stock [Member]
Shares Of Common Stock Reserved For Future Issuance [Line Items]
Convertible preferred stock	2,395,653

Redeemable convertible preferre

Redeemable convertible preferred stock (Detail) - Jun. 30, 2015 - USD ($)	Total
Redeemable Convertible Preferred Stock Series A-1 [Member]
Temporary Equity [Line Items]
Original Issue Price	$ 0.0100
Shares Designated	5,000,000
Shares Issued	5,000,000
Shares Outstanding	212,466
Liquidation Preference	$ 195,264
Redeemable Convertible Preferred Stock Series A-2 [Member]
Temporary Equity [Line Items]
Original Issue Price	$ 1.6996
Shares Designated	1,176,748
Shares Issued	1,176,748
Shares Outstanding	161,355
Liquidation Preference	$ 274,239
Series B Convertible Preferred Share [Member]
Temporary Equity [Line Items]
Original Issue Price	$ 1,000
Shares Designated	2,750
Shares Issued	2,750
Shares Outstanding	1,102
Liquidation Preference	$ 1,102,000

Common stock warrants outstandi

Common stock warrants outstanding (Detail) - Jun. 30, 2015 - $ / shares	Total
Warrant One [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Warrants Outstanding	500,000
Remaining Contractual Life (years)	6 years 8 months 1 day
Weighted Average Exercise	$ 1.14
Warrant Two [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Warrants Outstanding	108,697
Remaining Contractual Life (years)	4 years 9 months 7 days
Weighted Average Exercise	$ 0.46
Warrant Three [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Warrants Outstanding	57,611
Remaining Contractual Life (years)	4 years 9 months 7 days
Weighted Average Exercise	$ 0.58
Warrant Four [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Warrants Outstanding	26,989
Remaining Contractual Life (years)	4 years 7 months 28 days
Weighted Average Exercise	$ 2
Warrant Five [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Warrants Outstanding	247,500
Remaining Contractual Life (years)	4 years 4 months 2 days
Weighted Average Exercise	$ 2
Warrant Six [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Warrants Outstanding	238,412
Remaining Contractual Life (years)	3 years 7 months 2 days
Weighted Average Exercise	$ 3.04
Warrant Seven [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Warrants Outstanding	30,000
Remaining Contractual Life (years)	2 years 4 months 2 days
Weighted Average Exercise	$ 2.66
Warrant Eight [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Warrants Outstanding	586,238
Remaining Contractual Life (years)	1 year
Weighted Average Exercise	$ 2.66
Warrant Total [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Warrants Outstanding	1,795,447
Remaining Contractual Life (years)	3 years 9 months 22 days
Weighted Average Exercise	$ 1.99

Stock-Based Compensation - Addi

Stock-Based Compensation - Additional Information (Detail) - USD ($)	1 Months Ended	3 Months Ended		6 Months Ended
	Mar. 25, 2015	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014	Nov. 30, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, capital shares reserved for future issuance		7,432,828		7,432,828
Share-based compensation arrangement by share-based payment award, options, forfeitures in period				424,170
Share-based compensation arrangement by share-based payment award, options, vested, number of shares				4,509,238
Share Based Compensation Arrangements By Share Based Payment Award Options Assumed In Merger Weighted Average Exercise Price				$ 14.30
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Assumed In Merger				15,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value		$ 0		$ 0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross				7,167,585
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit	$ 2.05
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit	$ 3.85
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term				8 years 29 days
2013 Stock Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Employee service share-based compensation, nonvested awards, compensation cost not yet recognized, period for recognition				1 year 5 months 8 days
Non-employee service share-based compensation, nonvested awards, compensation not yet recognized, stock options		$ 122,659	$ 594,103	$ 216,672	$ 1,380,903
Non employee service share based compensation nonvested awards total compensation cost not yet recognized period for recognition1				$ 1,648,911
2013 Stock Plan [Member] | Board of Directors [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, capital shares reserved for future issuance						3,605,445
2014 Stock Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	1,432,661
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term	10 years
2014 Stock Plan [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term	4 years
2014 Stock Plan [Member] | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term	1 year
Stock option one [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	1,269,845
Stock option one [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term	3 years 1 month 6 days
Stock option one [Member] | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term	2 years 1 month 6 days
Stock Option Two [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage for closing price of common stock	48.00%
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	162,816
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price	$ 1.14

Common Stock Option and Restric

Common Stock Option and Restricted Stock Award Activity (Detail) - Jun. 30, 2015 - $ / shares	Total
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of Shares, Options Granted	7,167,585
Number Of Shares, Options Forfeited	(424,170)
Number of Shares, Total vested shares (options)	4,509,238
Weighted Average Exercise Price Per share, End of year	$ 1.56
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares Available for Grant, Beginning of year	689,529
Shares Available For Grant, Options Granted	(1,908,661)
Shares Available For Grant, Options Forfeited	619,864
Shares Available For Grant, Options Expired	60,091
Shares Available For Grant, Options canceled	1,432,661
Shares Available For Grant, Restricted Stock Granted	(394,267)
Shares Available For Grant, Restricted Stock Vested	0
Shares Available for Grant, End of year	499,217
Number of Shares, Beginning of Year	2,417,918
Number of Shares, Options Granted	1,908,661
Number Of Shares, Options Forfeited	(619,864)
Number Of Shares, Options Expired	(60,091)
Number Of Shares, Options canceled	(1,432,661)
Number of Shares, Restricted Stock Granted	394,267
Number of Shares, Restricted Stock Vested	(394,267)
Number of Shares, End of Year	2,213,963
Number of Shares, Total vested and expected to vest shares (options)	2,213,963
Number of Shares, Total vested shares (options)	948,833
Weighted Average Exercise Price Per share, Beginning of year	$ 2.59
Weighted Average Exercise Price Per Share, Options Granted	1.02
Weighted Average Exercise Price Per Share, Options Forfeited	1.14
Weighted Average Exercise Price Per Share, Options Expired	2.27
Weighted Average Exercise Price Per Share, Options canceled	2.73
Weighted Average Exercise Price Per Share, Restricted Stock Granted	0.39
Weighted Average Exercise Price Per Share, Restricted Stock Vested	0.39
Weighted Average Exercise Price Per share, End of year	1.56
Weighted Average Exercise Price Per Share, Total vested and expected to vest shares (options)	1.56
Weighted Average Exercise Price Per Share, Total vested shares (options)	$ 2.33

Summarizes Information with Res

Summarizes Information with Respect to Stock Options Outstanding (Detail) - $ / shares	6 Months Ended
	Jun. 30, 2015	Jan. 31, 2014	Dec. 17, 2013
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Price Per Share		$ 3.04	$ 2.66
Outstanding Options, Shares	2,213,963
Outstanding Options, Weighted- Average Remaining Contractual Term	8 years 29 days
Weighted Average- Exercise Price	$ 1.56
Exercisable Options, Shares	948,883
Exercisable Options, Weighted- Average Exercise Price	$ 2.33
Range of Exercise Prices - Range 1 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Price Per Share	$ 0.56
Outstanding Options, Shares	25,000
Outstanding Options, Weighted- Average Remaining Contractual Term	1 year 10 months 2 days
Weighted Average- Exercise Price	$ 0.56
Exercisable Options, Shares	25,000
Exercisable Options, Weighted- Average Exercise Price	$ 0.56
Range of Exercise Prices - Range 2 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Price Per Share	$ 0.69
Outstanding Options, Shares	326,000
Outstanding Options, Weighted- Average Remaining Contractual Term	9 years 6 months 29 days
Weighted Average- Exercise Price	$ 0.69
Exercisable Options, Shares	0
Exercisable Options, Weighted- Average Exercise Price	$ 0
Range of Exercise Prices - Range 3 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Price Per Share	$ 0.77
Outstanding Options, Shares	150,000
Outstanding Options, Weighted- Average Remaining Contractual Term	9 years 5 months 5 days
Weighted Average- Exercise Price	$ 0.77
Exercisable Options, Shares	25,000
Exercisable Options, Weighted- Average Exercise Price	$ 0.77
Range of Exercise Prices - Range 4 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Price Per Share	$ 1.14
Outstanding Options, Shares	990,818
Outstanding Options, Weighted- Average Remaining Contractual Term	8 years 3 months 29 days
Weighted Average- Exercise Price	$ 1.14
Exercisable Options, Shares	176,738
Exercisable Options, Weighted- Average Exercise Price	$ 1.14
Range of Exercise Prices - Range 5 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Price Per Share	$ 2.05
Outstanding Options, Shares	17,800
Outstanding Options, Weighted- Average Remaining Contractual Term	9 years 1 month 2 days
Weighted Average- Exercise Price	$ 2.05
Exercisable Options, Shares	17,800
Exercisable Options, Weighted- Average Exercise Price	$ 2.05
Range Of Exercise Prices - Range 6 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Price Per Share	$ 2.27
Outstanding Options, Shares	525,628
Outstanding Options, Weighted- Average Remaining Contractual Term	8 years 5 months 12 days
Weighted Average- Exercise Price	$ 2.27
Exercisable Options, Shares	525,628
Exercisable Options, Weighted- Average Exercise Price	$ 2.27
Range Of Exercise Prices - Range 7 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Price Per Share	$ 3.04
Outstanding Options, Shares	123,717
Outstanding Options, Weighted- Average Remaining Contractual Term	1 year 1 month 10 days
Weighted Average- Exercise Price	$ 3.04
Exercisable Options, Shares	123,717
Exercisable Options, Weighted- Average Exercise Price	$ 3.04
Range Of Exercise Prices - Range 8 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Price Per Share	$ 3.85
Outstanding Options, Shares	40,000
Outstanding Options, Weighted- Average Remaining Contractual Term	7 years 7 months 6 days
Weighted Average- Exercise Price	$ 3.85
Exercisable Options, Shares	40,000
Exercisable Options, Weighted- Average Exercise Price	$ 3.85
Range Of Exercise Prices - Range 9 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Price Per Share	$ 14.30
Outstanding Options, Shares	15,000
Outstanding Options, Weighted- Average Remaining Contractual Term	11 months 16 days
Weighted Average- Exercise Price	$ 14.30
Exercisable Options, Shares	15,000
Exercisable Options, Weighted- Average Exercise Price	$ 14.30

Fair Value of Employee Stock Op

Fair Value of Employee Stock Options Granted was Estimated Using Weighted Average Assumptions (Detail) - 6 months ended Jun. 30, 2015	Total
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected volatility	64.00%
Risk free rate	1.48%
Dividend yield	0.00%
Expected term (in years)	6 years 22 days

Employees and Non-Employees Rel

Employees and Non-Employees Related to Options and RSAs Recognized (Detail) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Operating expenses
General and administrative	$ 124,627	$ 865,922	$ 596,901	$ 1,861,654

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Detail) - USD ($)	1 Months Ended	3 Months Ended		6 Months Ended		32 Months Ended
	Mar. 31, 2014	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014	Aug. 31, 2017
Commitments and Contingencies [Line Items]
Security Deposit	$ 18,993
Operating Leases, Rent Expense		$ 27,168	$ 20,286	$ 54,320	$ 45,019
Future unconditional guarantee paid				$ 20,000,000
Discount Rate				12.00%
Subsequent Event [Member]
Commitments and Contingencies [Line Items]
Future unconditional guarantee paid						$ 20,000,000
Subsequent Event [Member] | Patents [Member]
Commitments and Contingencies [Line Items]
Payments for Fees						$ 18,000,000
Minimum [Member]
Commitments and Contingencies [Line Items]
Operating lease rent	9,200
Maximum [Member]
Commitments and Contingencies [Line Items]
Operating lease rent	$ 9,800

Future Minimum Annual Lease Pay

Future Minimum Annual Lease Payments (Detail)	Jun. 30, 2015USD ($)
Commitments and Contingencies [Line Items]
2,015	$ 57,136
2,016	116,201
2,017	68,587
Total	$ 241,924

Schedule of Future Guaranteed P

Schedule of Future Guaranteed Payments (Detail)	Jun. 30, 2015USD ($)
Liabilities for Guarantees on Long-Duration Contracts [Line Items]
2,015	$ 5,000,000
2,016	5,000,000
2,017	10,000,000
Less: discount to present value	(2,205,558)
Guaranteed payments, net of discount	$ 17,794,442

Fortress notes payable (Detail)

Fortress notes payable (Detail)	Jun. 30, 2015USD ($)
Commitments and Contingencies [Line Items]
2,015	$ 1,578,107
2,016	6,433,856
2,017	4,955,250
Total	$ 12,967,213